| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC19P H2BC12 H2BC18 | 4.04e-18 | 100 | 82 | 14 | GO:0030527 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ZNF318 H2BC19P BHLHE40 H2BC12 H2BC18 | 5.79e-12 | 398 | 82 | 16 | GO:0046982 |
| GeneOntologyMolecularFunction | structural molecule activity | H2BC12L H2BC11 RPL27 DLGAP1 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SHANK2 MYOM1 H2BC5 H2BC3 H2BC19P NEB H2BC12 H2BC18 | 2.50e-09 | 891 | 82 | 19 | GO:0005198 |
| GeneOntologyMolecularFunction | protein dimerization activity | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 MYOM1 ANKRD11 H2BC5 H2BC3 CEP131 ZNF318 H2BC19P STARD3NL BHLHE40 H2BC12 H2BC18 | 6.00e-08 | 1205 | 82 | 20 | GO:0046983 |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-phosphate 5-kinase activity | 4.98e-05 | 3 | 82 | 2 | GO:0000285 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-5-kinase activity | 4.98e-05 | 3 | 82 | 2 | GO:0052810 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.69e-04 | 37 | 82 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 5.89e-04 | 9 | 82 | 2 | GO:0016308 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 8.94e-04 | 11 | 82 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | STAT family protein binding | 1.26e-03 | 13 | 82 | 2 | GO:0097677 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 1.26e-03 | 13 | 82 | 2 | GO:0098879 | |
| GeneOntologyBiologicalProcess | nucleosome organization | H2BC11 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H SMARCA2 H2BC3 | 2.44e-13 | 142 | 79 | 12 | GO:0034728 |
| GeneOntologyBiologicalProcess | nucleosome assembly | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H SMARCA2 H2BC3 | 1.26e-12 | 122 | 79 | 11 | GO:0006334 |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2BC11 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF CHD5 SUPT16H SMARCA2 H2BC3 RERE KMT2E JMJD1C HELLS | 2.86e-10 | 741 | 79 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | innate immune response in mucosa | 1.44e-09 | 30 | 79 | 6 | GO:0002227 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H SMARCA2 H2BC3 | 2.79e-09 | 249 | 79 | 11 | GO:0065004 |
| GeneOntologyBiologicalProcess | chromatin organization | H2BC11 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF CHD5 SUPT16H SMARCA2 H2BC3 RERE KMT2E JMJD1C HELLS | 5.78e-09 | 896 | 79 | 18 | GO:0006325 |
| GeneOntologyBiologicalProcess | mucosal immune response | 2.81e-08 | 48 | 79 | 6 | GO:0002385 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H2BC11 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF CHD5 SUPT16H SMARCA2 H2BC3 RERE KMT2E JMJD1C HELLS | 3.09e-08 | 999 | 79 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | organ or tissue specific immune response | 5.81e-08 | 54 | 79 | 6 | GO:0002251 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 8.95e-07 | 85 | 79 | 6 | GO:0019731 | |
| GeneOntologyBiologicalProcess | mRNA processing | SART1 SNRNP25 RBM25 LUC7L2 ZC3H13 DHX38 RBM26 SLTM RBM6 BUD13 IK CWC25 | 1.18e-06 | 551 | 79 | 12 | GO:0006397 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 9.13e-06 | 358 | 79 | 9 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9.13e-06 | 358 | 79 | 9 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 9.98e-06 | 362 | 79 | 9 | GO:0000375 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 1.27e-05 | 134 | 79 | 6 | GO:0061844 | |
| GeneOntologyBiologicalProcess | RNA splicing | 2.14e-05 | 502 | 79 | 10 | GO:0008380 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 2.40e-05 | 150 | 79 | 6 | GO:0050830 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 7.99e-05 | 186 | 79 | 6 | GO:0019730 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | SART1 SNRNP25 RBM25 LUC7L2 ZC3H13 DHX38 RBM26 SLTM RBM6 BUD13 IK CWC25 | 1.82e-04 | 917 | 79 | 12 | GO:0016071 |
| GeneOntologyBiologicalProcess | RNA processing | SART1 UTP6 SNRNP25 RPL27 SEPSECS RBM25 LUC7L2 ZC3H13 DHX38 RBM26 SLTM RBM6 BUD13 IK CWC25 | 5.05e-04 | 1500 | 79 | 15 | GO:0006396 |
| GeneOntologyBiologicalProcess | protein localization to chromosome, centromeric region | 5.57e-04 | 42 | 79 | 3 | GO:0071459 | |
| GeneOntologyCellularComponent | nucleosome | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC19P H2BC12 H2BC18 | 2.28e-16 | 138 | 82 | 14 | GO:0000786 |
| GeneOntologyCellularComponent | chromatin | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CHD5 HMGXB4 SUPT16H SMARCA2 ANKRD11 H2BC5 H2BC3 TSHZ1 H2BC19P KMT2E BHLHE40 JMJD1C H2BC12 H2BC18 HELLS | 1.25e-09 | 1480 | 82 | 24 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear speck | SART1 NUGGC RBM25 LUC7L2 ZC3H13 CHD5 PIP5K1A ZC3H18 IK KMT2E CWC25 | 9.48e-07 | 431 | 82 | 11 | GO:0016607 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | BCLAF3 SART1 UTP6 SNRNP25 LUC7L2 TLE3 CHD5 DHX38 HMGXB4 SUPT16H SMARCA2 PIP5K1A BUD13 RERE IK KMT2E CWC25 JMJD1C | 5.01e-06 | 1377 | 82 | 18 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear body | SART1 NUGGC RBM25 LUC7L2 ZC3H13 CHD5 SLTM PIP5K1A ZC3H18 RERE IK KMT2E CWC25 BHLHE40 | 1.01e-05 | 903 | 82 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | spliceosomal complex | 2.18e-05 | 215 | 82 | 7 | GO:0005681 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 3.99e-05 | 97 | 82 | 5 | GO:0005684 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 3.50e-04 | 85 | 82 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | U2-type precatalytic spliceosome | 1.06e-03 | 51 | 82 | 3 | GO:0071005 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 1.25e-03 | 54 | 82 | 3 | GO:0071011 | |
| HumanPheno | Downslanted palpebral fissures | MYH3 SETD2 CTCF DOK7 SUPT16H SMARCA2 ANKRD11 DNAJC21 UMPS RERE KMT2E JMJD1C RYR1 | 3.46e-07 | 497 | 27 | 13 | HP:0000494 |
| HumanPheno | Slanting of the palpebral fissure | MYH3 SETD2 CTCF DOK7 CHD5 SUPT16H SMARCA2 ANKRD11 SASS6 DNAJC21 UMPS RERE KMT2E JMJD1C RYR1 | 7.33e-07 | 739 | 27 | 15 | HP:0200006 |
| HumanPheno | Hypertelorism | RPL27 MYH3 SETD2 CTCF DOK7 SUPT16H SMARCA2 ANKRD11 DNAJC21 UMPS RERE NEB JMJD1C RYR1 HELLS | 3.37e-06 | 830 | 27 | 15 | HP:0000316 |
| HumanPheno | Micrognathia | RPL27 MYH3 SETD2 CTCF PYROXD1 DOK7 CHD5 SUPT16H ANKRD11 DNAJC21 ROBO1 RERE NEB JMJD1C HELLS | 4.12e-06 | 843 | 27 | 15 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | RPL27 MYH3 SETD2 CTCF PYROXD1 DOK7 CHD5 SUPT16H ANKRD11 DNAJC21 ROBO1 RERE NEB JMJD1C HELLS | 4.25e-06 | 845 | 27 | 15 | HP:0009118 |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | RPL27 MYH3 SETD2 CTCF PYROXD1 DOK7 CHD5 SUPT16H ANKRD11 DNAJC21 ROBO1 RERE IHH NEB JMJD1C HELLS | 7.06e-06 | 1008 | 27 | 16 | HP:0009122 |
| HumanPheno | Abnormality of the palpebral fissures | MYH3 SETD2 CTCF DOK7 CHD5 SUPT16H SMARCA2 ANKRD11 SASS6 DNAJC21 UMPS RERE KMT2E JMJD1C RYR1 | 7.16e-06 | 880 | 27 | 15 | HP:0008050 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | RPL27 MYH3 SETD2 CTCF PYROXD1 DOK7 CHD5 SUPT16H ANKRD11 DNAJC21 ROBO1 RERE NEB JMJD1C HELLS | 1.18e-05 | 915 | 27 | 15 | HP:0009116 |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | RPL27 MYH3 SETD2 CTCF PYROXD1 DOK7 CHD5 SUPT16H SMARCA2 ANKRD11 DNAJC21 ROBO1 RERE IHH NEB JMJD1C RYR1 HELLS | 1.28e-05 | 1343 | 27 | 18 | HP:0009115 |
| HumanPheno | Abnormal mandible morphology | RPL27 MYH3 SETD2 CTCF PYROXD1 DOK7 CHD5 SUPT16H ANKRD11 DNAJC21 ROBO1 RERE NEB JMJD1C RYR1 HELLS | 2.85e-05 | 1118 | 27 | 16 | HP:0000277 |
| HumanPheno | Abnormality of globe location | RPL27 MYH3 SETD2 CTCF DOK7 SUPT16H SMARCA2 ANKRD11 DNAJC21 UMPS RERE NEB KMT2E JMJD1C RYR1 HELLS | 2.98e-05 | 1122 | 27 | 16 | HP:0100886 |
| HumanPheno | Long face | 3.82e-05 | 259 | 27 | 8 | HP:0000276 | |
| HumanPheno | Abnormal neck morphology | RPL27 MYH3 CTCF PYROXD1 DOK7 SUPT16H SMARCA2 ANKRD11 NLRP1 RERE NEB JMJD1C RYR1 | 4.70e-05 | 766 | 27 | 13 | HP:0025668 |
| HumanPheno | Abnormal brainstem morphology | 4.98e-05 | 352 | 27 | 9 | HP:0002363 | |
| HumanPheno | Abnormality of the jaws | RPL27 MYH3 SETD2 CTCF PYROXD1 DOK7 CHD5 SUPT16H ANKRD11 DNAJC21 ROBO1 RERE NEB JMJD1C RYR1 HELLS | 5.48e-05 | 1175 | 27 | 16 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | RPL27 MYH3 SETD2 CTCF PYROXD1 DOK7 CHD5 SUPT16H ANKRD11 DNAJC21 ROBO1 RERE NEB JMJD1C RYR1 HELLS | 5.54e-05 | 1176 | 27 | 16 | HP:0030791 |
| HumanPheno | Large face | 7.22e-05 | 283 | 27 | 8 | HP:0100729 | |
| HumanPheno | Abnormal location of ears | RPL27 MYH3 CTCF DOK7 CHD5 SUPT16H SMARCA2 ANKRD11 UMPS RERE NEB JMJD1C RYR1 HELLS | 9.37e-05 | 945 | 27 | 14 | HP:0000357 |
| HumanPheno | Hypoplasia of the pons | 9.64e-05 | 91 | 27 | 5 | HP:0012110 | |
| HumanPheno | Abnormal finger morphology | RPL27 MYH3 CTCF PYROXD1 DOK7 SUPT16H SMARCA2 ANKRD11 DNAJC21 ROBO1 NLRP1 RERE IHH NEB KMT2E JMJD1C RYR1 | 1.02e-04 | 1385 | 27 | 17 | HP:0001167 |
| HumanPheno | Abnormality of globe location or size | RPL27 MYH3 SETD2 CTCF DOK7 SUPT16H SMARCA2 ANKRD11 DNAJC21 UMPS RERE NEB KMT2E JMJD1C RYR1 HELLS | 1.17e-04 | 1246 | 27 | 16 | HP:0000489 |
| HumanPheno | Nemaline bodies | 1.22e-04 | 19 | 27 | 3 | HP:0003798 | |
| HumanPheno | Abnormal eyelid morphology | RPL27 MYH3 SETD2 CTCF DOK7 CHD5 SUPT16H SMARCA2 ANKRD11 SASS6 DNAJC21 UMPS RERE KMT2E JMJD1C RYR1 HELLS | 1.28e-04 | 1408 | 27 | 17 | HP:0000492 |
| HumanPheno | Epicanthus | RPL27 MYH3 CTCF CHD5 SUPT16H SMARCA2 DNAJC21 RERE JMJD1C RYR1 HELLS | 1.51e-04 | 614 | 27 | 11 | HP:0000286 |
| HumanPheno | Wide nasal bridge | 1.57e-04 | 508 | 27 | 10 | HP:0000431 | |
| HumanPheno | Abnormality of the neck | RPL27 MYH3 CTCF PYROXD1 DOK7 SUPT16H SMARCA2 ANKRD11 NLRP1 RERE NEB JMJD1C RYR1 | 1.58e-04 | 858 | 27 | 13 | HP:0000464 |
| HumanPheno | Narrow mouth | 1.59e-04 | 234 | 27 | 7 | HP:0000160 | |
| HumanPheno | Sternocleidomastoid amyotrophy | 1.61e-04 | 4 | 27 | 2 | HP:0012036 | |
| HumanPheno | Central core regions in muscle fibers | 1.61e-04 | 4 | 27 | 2 | HP:0030230 | |
| HumanPheno | Low hanging columella | 1.91e-04 | 56 | 27 | 4 | HP:0009765 | |
| HumanPheno | Ptosis | RPL27 MYH3 CTCF PYROXD1 DOK7 SMARCA2 ANKRD11 ROBO1 RERE NEB JMJD1C RYR1 | 2.06e-04 | 754 | 27 | 12 | HP:0000508 |
| HumanPheno | Abnormality of mouth size | 2.16e-04 | 425 | 27 | 9 | HP:0011337 | |
| HumanPheno | Hip dysplasia | 2.23e-04 | 247 | 27 | 7 | HP:0001385 | |
| HumanPheno | Abnormal nasal bridge morphology | RPL27 MYH3 SETD2 CTCF DOK7 CHD5 SUPT16H SMARCA2 ANKRD11 UMPS RERE JMJD1C RYR1 HELLS | 2.45e-04 | 1029 | 27 | 14 | HP:0000422 |
| HumanPheno | Abnormality of the outer ear | RPL27 MYH3 CTCF DOK7 CHD5 SUPT16H SMARCA2 ANKRD11 DNAJC21 UMPS TSHZ1 RERE NEB JMJD1C RYR1 HELLS | 2.87e-04 | 1337 | 27 | 16 | HP:0000356 |
| HumanPheno | Abnormality of the palmar creases | 3.06e-04 | 260 | 27 | 7 | HP:0010490 | |
| HumanPheno | Abnormal pons morphology | 3.16e-04 | 117 | 27 | 5 | HP:0007361 | |
| HumanPheno | Abnormal palmar dermatoglyphics | 3.44e-04 | 265 | 27 | 7 | HP:0001018 | |
| HumanPheno | Cupped ear | 4.28e-04 | 69 | 27 | 4 | HP:0000378 | |
| HumanPheno | Reduced vital capacity | 4.43e-04 | 29 | 27 | 3 | HP:0002792 | |
| HumanPheno | Posteriorly rotated ears | 4.63e-04 | 470 | 27 | 9 | HP:0000358 | |
| HumanPheno | Talipes | 4.90e-04 | 583 | 27 | 10 | HP:0001883 | |
| HumanPheno | Conductive hearing impairment | 4.93e-04 | 373 | 27 | 8 | HP:0000405 | |
| HumanPheno | Positional foot deformity | 5.18e-04 | 587 | 27 | 10 | HP:0005656 | |
| HumanPheno | Abnormal heart valve morphology | RPL27 MYH3 CTCF PYROXD1 SUPT16H ANKRD11 ROBO1 RERE JMJD1C RYR1 | 5.25e-04 | 588 | 27 | 10 | HP:0001654 |
| HumanPheno | Highly arched eyebrow | 5.90e-04 | 206 | 27 | 6 | HP:0002553 | |
| HumanPheno | Muscle fiber cytoplasmatic inclusion bodies | 5.95e-04 | 32 | 27 | 3 | HP:0100303 | |
| HumanPheno | Functional abnormality of the middle ear | 6.21e-04 | 386 | 27 | 8 | HP:0011452 | |
| HumanPheno | Abnormal nasal tip morphology | 6.21e-04 | 386 | 27 | 8 | HP:0000436 | |
| HumanPheno | Abnormal upper lip morphology | MYH3 CTCF CHD5 SUPT16H SMARCA2 ANKRD11 SASS6 ROBO1 NLRP1 RERE NEB JMJD1C RYR1 | 6.24e-04 | 980 | 27 | 13 | HP:0000177 |
| HumanPheno | Abnormal hip joint morphology | 6.31e-04 | 490 | 27 | 9 | HP:0001384 | |
| HumanPheno | Abnormality of the hairline | 6.48e-04 | 294 | 27 | 7 | HP:0009553 | |
| HumanPheno | Abnormality of the philtrum | MYH3 CTCF CHD5 SMARCA2 ANKRD11 ROBO1 NLRP1 RERE NEB JMJD1C RYR1 | 6.72e-04 | 726 | 27 | 11 | HP:0000288 |
| HumanPheno | Pointed chin | 6.77e-04 | 138 | 27 | 5 | HP:0000307 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | MYH3 CTCF DOK7 SMARCA2 ANKRD11 DNAJC21 UMPS RERE IHH NEB RYR1 | 7.05e-04 | 730 | 27 | 11 | HP:0002644 |
| HumanPheno | Fetal akinesia sequence | 7.12e-04 | 34 | 27 | 3 | HP:0001989 | |
| HumanPheno | Single transverse palmar crease | 7.40e-04 | 215 | 27 | 6 | HP:0000954 | |
| HumanPheno | Short neck | 7.63e-04 | 398 | 27 | 8 | HP:0000470 | |
| HumanPheno | Abnormal synovial membrane morphology | 7.65e-04 | 503 | 27 | 9 | HP:0005262 | |
| HumanPheno | Abnormal pinna morphology | RPL27 MYH3 CTCF DOK7 CHD5 SUPT16H SMARCA2 ANKRD11 DNAJC21 UMPS RERE NEB JMJD1C RYR1 HELLS | 8.18e-04 | 1299 | 27 | 15 | HP:0000377 |
| HumanPheno | Abnormal thumb morphology | 9.00e-04 | 408 | 27 | 8 | HP:0001172 | |
| HumanPheno | Abnormal dermatoglyphics | 9.60e-04 | 314 | 27 | 7 | HP:0007477 | |
| HumanPheno | Abnormal skin morphology of the palm | 9.76e-04 | 413 | 27 | 8 | HP:0040211 | |
| HumanPheno | Generalized amyotrophy | 9.88e-04 | 86 | 27 | 4 | HP:0003700 | |
| HumanPheno | Abnormal palm morphology | 9.89e-04 | 521 | 27 | 9 | HP:0100871 | |
| HumanPheno | Abnormality of lower limb joint | MYH3 CTCF PYROXD1 DOK7 SMARCA2 ANKRD11 DNAJC21 UMPS RERE IHH NEB JMJD1C RYR1 | 9.96e-04 | 1027 | 27 | 13 | HP:0100491 |
| HumanPheno | Low-set ears | RPL27 MYH3 CTCF CHD5 SUPT16H SMARCA2 RERE NEB JMJD1C RYR1 HELLS | 1.01e-03 | 761 | 27 | 11 | HP:0000369 |
| HumanPheno | Muscle fiber inclusion bodies | 1.15e-03 | 40 | 27 | 3 | HP:0100299 | |
| HumanPheno | Abnormal hip bone morphology | 1.21e-03 | 653 | 27 | 10 | HP:0003272 | |
| HumanPheno | Congenital abnormal hair pattern | 1.22e-03 | 327 | 27 | 7 | HP:0011361 | |
| HumanPheno | Easy fatigability | 1.22e-03 | 91 | 27 | 4 | HP:0003388 | |
| HumanPheno | Cryptorchidism | MYH3 CTCF DOK7 SMARCA2 ANKRD11 DNAJC21 ROBO1 RERE KMT2E JMJD1C RYR1 | 1.25e-03 | 780 | 27 | 11 | HP:0000028 |
| HumanPheno | Long philtrum | 1.25e-03 | 429 | 27 | 8 | HP:0000343 | |
| HumanPheno | Upslanted palpebral fissure | 1.36e-03 | 333 | 27 | 7 | HP:0000582 | |
| HumanPheno | Abnormality of the forehead | RPL27 MYH3 SETD2 SEPSECS CTCF CHD5 SUPT16H SMARCA2 ANKRD11 SASS6 ROBO1 RERE KMT2E RYR1 | 1.38e-03 | 1208 | 27 | 14 | HP:0000290 |
| HumanPheno | Foot joint contracture | 1.38e-03 | 334 | 27 | 7 | HP:0008366 | |
| HumanPheno | Abnormal rib morphology | 1.43e-03 | 336 | 27 | 7 | HP:0000772 | |
| HumanPheno | Abnormality of the cervical spine | 1.46e-03 | 439 | 27 | 8 | HP:0003319 | |
| HumanPheno | Abnormal columella morphology | 1.55e-03 | 97 | 27 | 4 | HP:0009929 | |
| HumanPheno | Triangular face | 1.60e-03 | 167 | 27 | 5 | HP:0000325 | |
| HumanPheno | Disinhibition | SETD2 CTCF CHD5 SUPT16H SMARCA2 ANKRD11 SASS6 DNAJC21 RERE KMT2E JMJD1C | 1.66e-03 | 807 | 27 | 11 | HP:0000734 |
| HumanPheno | Inappropriate behavior | SETD2 CTCF CHD5 SUPT16H SMARCA2 ANKRD11 SASS6 DNAJC21 RERE KMT2E JMJD1C | 1.66e-03 | 807 | 27 | 11 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | SETD2 CTCF CHD5 SUPT16H SMARCA2 ANKRD11 SASS6 DNAJC21 RERE KMT2E JMJD1C | 1.66e-03 | 807 | 27 | 11 | HP:5200123 |
| HumanPheno | Social disinhibition | SETD2 CTCF CHD5 SUPT16H SMARCA2 ANKRD11 SASS6 DNAJC21 RERE KMT2E JMJD1C | 1.66e-03 | 807 | 27 | 11 | HP:5200029 |
| HumanPheno | Skin-picking | 1.73e-03 | 12 | 27 | 2 | HP:0012166 | |
| HumanPheno | Abnormal atrioventricular valve morphology | 1.82e-03 | 350 | 27 | 7 | HP:0006705 | |
| HumanPheno | Orofacial cleft | 1.95e-03 | 694 | 27 | 10 | HP:0000202 | |
| HumanPheno | Craniofacial cleft | 1.95e-03 | 694 | 27 | 10 | HP:5201015 | |
| HumanPheno | Abnormal lip morphology | RPL27 MYH3 CTCF CHD5 SUPT16H SMARCA2 ANKRD11 SASS6 ROBO1 NLRP1 RERE NEB JMJD1C RYR1 | 1.96e-03 | 1249 | 27 | 14 | HP:0000159 |
| HumanPheno | Rib fusion | 1.96e-03 | 48 | 27 | 3 | HP:0000902 | |
| HumanPheno | Absent palmar crease | 2.04e-03 | 13 | 27 | 2 | HP:0010489 | |
| Domain | H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 3.48e-29 | 21 | 82 | 14 | SM00427 |
| Domain | HISTONE_H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 3.48e-29 | 21 | 82 | 14 | PS00357 |
| Domain | Histone_H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 3.48e-29 | 21 | 82 | 14 | IPR000558 |
| Domain | Histone | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 1.54e-21 | 56 | 82 | 14 | PF00125 |
| Domain | Histone_H2A/H2B/H3 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 1.54e-21 | 56 | 82 | 14 | IPR007125 |
| Domain | Histone-fold | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 6.41e-19 | 83 | 82 | 14 | IPR009072 |
| Domain | - | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 8.65e-15 | 69 | 82 | 11 | 1.10.20.10 |
| Domain | - | 1.89e-04 | 5 | 82 | 2 | 1.20.1390.10 | |
| Domain | PWI | 1.89e-04 | 5 | 82 | 2 | PF01480 | |
| Domain | PWI_dom | 1.89e-04 | 5 | 82 | 2 | IPR002483 | |
| Domain | SNF2_N | 3.69e-04 | 32 | 82 | 3 | IPR000330 | |
| Domain | SNF2_N | 3.69e-04 | 32 | 82 | 3 | PF00176 | |
| Domain | PInositol-4-P-5-kinase | 3.94e-04 | 7 | 82 | 2 | IPR023610 | |
| Domain | PIPKc | 5.24e-04 | 8 | 82 | 2 | SM00330 | |
| Domain | - | 5.24e-04 | 8 | 82 | 2 | 3.30.800.10 | |
| Domain | PIP5K | 5.24e-04 | 8 | 82 | 2 | PF01504 | |
| Domain | PIPK | 5.24e-04 | 8 | 82 | 2 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 5.24e-04 | 8 | 82 | 2 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 5.24e-04 | 8 | 82 | 2 | IPR027483 | |
| Domain | - | 5.24e-04 | 8 | 82 | 2 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 5.24e-04 | 8 | 82 | 2 | IPR002498 | |
| Domain | - | 7.17e-04 | 40 | 82 | 3 | 4.10.1000.10 | |
| Domain | ZnF_C3H1 | 1.22e-03 | 48 | 82 | 3 | SM00356 | |
| Domain | Helicase_C | 1.26e-03 | 107 | 82 | 4 | PF00271 | |
| Domain | HELICc | 1.26e-03 | 107 | 82 | 4 | SM00490 | |
| Domain | Helicase_C | 1.31e-03 | 108 | 82 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.35e-03 | 109 | 82 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.35e-03 | 109 | 82 | 4 | PS51192 | |
| Domain | DEXDc | 1.35e-03 | 109 | 82 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.40e-03 | 110 | 82 | 4 | IPR014001 | |
| Domain | Znf_CCCH | 2.12e-03 | 58 | 82 | 3 | IPR000571 | |
| Domain | ZF_C3H1 | 2.12e-03 | 58 | 82 | 3 | PS50103 | |
| Domain | ZnF_U1 | 7.16e-03 | 29 | 82 | 2 | SM00451 | |
| Domain | Znf_U1 | 7.16e-03 | 29 | 82 | 2 | IPR003604 | |
| Pathway | REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.09e-19 | 42 | 63 | 12 | M48029 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.92e-18 | 55 | 63 | 12 | M29526 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 UBXN1 H2BC12 | 1.34e-17 | 78 | 63 | 13 | M27589 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.81e-17 | 62 | 63 | 12 | M27700 |
| Pathway | REACTOME_DNA_METHYLATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.75e-17 | 64 | 63 | 12 | M27429 |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.56e-17 | 66 | 63 | 12 | M27488 |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.04e-16 | 67 | 63 | 12 | M27342 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.04e-16 | 67 | 63 | 12 | M39003 |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 TLE3 H2BC5 H2BC3 H2BC12 | 1.12e-16 | 91 | 63 | 13 | M27101 |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.26e-16 | 68 | 63 | 12 | M27658 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.26e-16 | 68 | 63 | 12 | M27587 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.83e-16 | 70 | 63 | 12 | M48261 |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.83e-16 | 70 | 63 | 12 | M48028 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.62e-16 | 72 | 63 | 12 | M29714 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.62e-16 | 72 | 63 | 12 | M27132 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SMARCA2 H2BC5 H2BC3 H2BC12 | 2.66e-16 | 97 | 63 | 13 | M48262 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.12e-16 | 73 | 63 | 12 | M27166 |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.41e-16 | 75 | 63 | 12 | M27343 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.26e-16 | 78 | 63 | 12 | M1061 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.53e-16 | 79 | 63 | 12 | M27191 |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.32e-15 | 88 | 63 | 12 | M1011 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.82e-15 | 89 | 63 | 12 | M27943 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.40e-15 | 90 | 63 | 12 | M2158 |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.40e-15 | 90 | 63 | 12 | M27691 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.40e-15 | 90 | 63 | 12 | M29668 |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF H2BC5 H2BC3 H2BC12 | 5.78e-15 | 122 | 63 | 13 | M29689 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.62e-15 | 93 | 63 | 12 | M27487 |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.56e-15 | 94 | 63 | 12 | M1080 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 7.56e-15 | 94 | 63 | 12 | M27230 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.83e-15 | 96 | 63 | 12 | M27792 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.12e-14 | 97 | 63 | 12 | M27590 |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.65e-14 | 104 | 63 | 12 | M29829 |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.98e-14 | 105 | 63 | 12 | M27425 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.35e-14 | 106 | 63 | 12 | M27458 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.76e-14 | 107 | 63 | 12 | M48260 |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.21e-14 | 108 | 63 | 12 | M27426 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SMARCA2 H2BC5 H2BC3 H2BC12 | 4.28e-14 | 142 | 63 | 13 | M48257 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.28e-14 | 110 | 63 | 12 | M27958 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.28e-14 | 110 | 63 | 12 | M27696 |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.90e-14 | 111 | 63 | 12 | M27187 |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.58e-14 | 112 | 63 | 12 | M48334 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.58e-14 | 112 | 63 | 12 | M4052 |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 7.97e-14 | 59 | 63 | 10 | M27763 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 TLE3 H2BC5 H2BC3 H2BC12 | 8.04e-14 | 149 | 63 | 13 | M27888 |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.01e-13 | 116 | 63 | 12 | M29806 |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.38e-13 | 119 | 63 | 12 | M607 |
| Pathway | REACTOME_MEIOSIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.53e-13 | 120 | 63 | 12 | M529 |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.51e-13 | 125 | 63 | 12 | M27186 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.35e-13 | 128 | 63 | 12 | M48019 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | PKMYT1 H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.54e-13 | 167 | 63 | 13 | M19381 |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.68e-13 | 129 | 63 | 12 | M27795 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 UBXN1 H2BC12 | 4.46e-13 | 170 | 63 | 13 | M27582 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 8.32e-13 | 138 | 63 | 12 | M29805 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 9.07e-13 | 139 | 63 | 12 | M4741 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.07e-13 | 139 | 63 | 12 | M715 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.07e-13 | 139 | 63 | 12 | M868 |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.89e-13 | 140 | 63 | 12 | M27584 |
| Pathway | REACTOME_MITOTIC_PROPHASE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.17e-12 | 142 | 63 | 12 | M27660 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.17e-12 | 142 | 63 | 12 | M27233 |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 TLE3 H2BC5 H2BC3 PIP5K1B H2BC12 | 1.40e-12 | 233 | 63 | 14 | M27099 |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 1.71e-12 | 79 | 63 | 10 | M27742 |
| Pathway | REACTOME_REPRODUCTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.20e-12 | 158 | 63 | 12 | M26956 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.53e-12 | 159 | 63 | 12 | M27665 |
| Pathway | REACTOME_HCMV_INFECTION | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.66e-12 | 162 | 63 | 12 | M29804 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SMARCA2 H2BC5 H2BC3 H2BC12 H2BC18 | 1.14e-11 | 272 | 63 | 14 | M29619 |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 TLE3 H2BC5 H2BC3 H2BC12 | 1.20e-11 | 220 | 63 | 13 | M27794 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 2.29e-11 | 46 | 63 | 8 | MM14935 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SMARCA2 H2BC5 H2BC3 H2BC12 | 3.07e-11 | 237 | 63 | 13 | M27786 |
| Pathway | REACTOME_DNA_REPLICATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.08e-11 | 187 | 63 | 12 | M1017 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 TLE3 H2BC5 H2BC3 H2BC12 | 4.89e-11 | 246 | 63 | 13 | M10189 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.67e-11 | 197 | 63 | 12 | M27188 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SMARCA2 H2BC5 H2BC3 H2BC12 | 7.30e-11 | 254 | 63 | 13 | M27131 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 1.04e-10 | 55 | 63 | 8 | MM14932 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 TLE3 H2BC5 H2BC3 PIP5K1B H2BC12 | 1.50e-10 | 330 | 63 | 14 | M7847 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.16e-10 | 221 | 63 | 12 | M27578 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | PKMYT1 H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.93e-10 | 291 | 63 | 13 | M16647 |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 TLE3 H2BC5 H2BC3 H2BC12 | 4.85e-10 | 296 | 63 | 13 | M27869 |
| Pathway | REACTOME_DNA_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 UBXN1 H2BC12 | 1.97e-09 | 332 | 63 | 13 | M15434 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 4.21e-09 | 31 | 63 | 6 | MM17225 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 5.61e-09 | 57 | 63 | 7 | MM15298 | |
| Pathway | REACTOME_DEUBIQUITINATION | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 6.76e-09 | 299 | 63 | 12 | M27574 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.15e-08 | 63 | 63 | 7 | MM15613 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 1.30e-08 | 37 | 63 | 6 | MM14883 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 1.54e-08 | 38 | 63 | 6 | MM15434 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.60e-08 | 323 | 63 | 12 | M27080 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 1.82e-08 | 39 | 63 | 6 | MM14850 | |
| Pathway | REACTOME_M_PHASE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CEP131 H2BC12 | 3.01e-08 | 417 | 63 | 13 | M27662 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 3.86e-08 | 44 | 63 | 6 | MM15527 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 4.44e-08 | 45 | 63 | 6 | MM15508 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 5.81e-08 | 47 | 63 | 6 | MM15296 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 7.58e-08 | 175 | 63 | 9 | MM14941 | |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 8.51e-08 | 50 | 63 | 6 | MM15308 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | PKMYT1 H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 CEP131 H2BC12 | 1.31e-07 | 561 | 63 | 14 | M5336 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 1.36e-07 | 54 | 63 | 6 | MM14904 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.70e-07 | 56 | 63 | 6 | MM17236 | |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 4.20e-07 | 65 | 63 | 6 | MM15490 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 5.04e-07 | 67 | 63 | 6 | MM15429 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 7.75e-07 | 72 | 63 | 6 | MM15381 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 9.13e-07 | 74 | 63 | 6 | MM14605 | |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | 9.89e-07 | 75 | 63 | 6 | MM15299 | |
| Pubmed | Inhibition of core histones acetylation by carcinogenic nickel(II). | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 2.22e-34 | 18 | 84 | 14 | 16283522 |
| Pubmed | Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 2.22e-34 | 18 | 84 | 14 | 12757711 |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 SUPT16H H2BC5 H2BC3 H2BC12 H2BC18 | 1.75e-29 | 22 | 84 | 13 | 16713563 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.29e-26 | 23 | 84 | 12 | 16307923 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.45e-24 | 30 | 84 | 12 | 16319397 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 5.46e-23 | 77 | 84 | 14 | 12408966 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | H2BC12L SART1 RPL27 SETD2 H2BC13 RBM25 H2BC15 H2BC14 H2BC9 CTCF ZC3H13 HMGXB4 SUPT16H RBM26 SLTM ANKRD11 RBM6 H2BC5 BUD13 ZC3H18 ZNF318 IK CWC25 JMJD1C H2BC12 H2BC18 HELLS | 8.05e-22 | 954 | 84 | 27 | 36373674 |
| Pubmed | Quantitative proteomic analysis of post-translational modifications of human histones. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 4.30e-20 | 17 | 84 | 9 | 16627869 |
| Pubmed | 1.35e-19 | 11 | 84 | 8 | 15197225 | ||
| Pubmed | Histone modifications associated with somatic hypermutation. | 1.35e-19 | 11 | 84 | 8 | 16039583 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 SMARCA2 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 1.91e-18 | 203 | 84 | 15 | 16916647 |
| Pubmed | H2BC11 RPL27 MYH3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 LUC7L2 SUPT16H H2BC5 H2BC3 UBXN1 H2BC12 H2BC18 | 3.69e-18 | 212 | 84 | 15 | 23463506 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | H2BC11 H2BC13 RBM25 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CHD5 RBM26 H2BC5 H2BC3 ZNF318 H2BC12 H2BC18 | 4.70e-18 | 271 | 84 | 16 | 32433965 |
| Pubmed | Histone H2B as a functionally important plasminogen receptor on macrophages. | 5.22e-18 | 15 | 84 | 8 | 17690254 | |
| Pubmed | H2BC11 RPL27 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 9.51e-18 | 67 | 84 | 11 | 25253489 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.34e-17 | 69 | 84 | 11 | 11689053 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.60e-17 | 73 | 84 | 11 | 14657027 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.60e-17 | 73 | 84 | 11 | 9566873 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.75e-16 | 86 | 84 | 11 | 11080476 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | H2BC12L SART1 H2BC11 RPL27 H2BC13 RBM25 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 ZC3H13 SUPT16H H2BC5 H2BC3 H2BC12 H2BC18 | 1.78e-15 | 477 | 84 | 17 | 31300519 |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | H2BC12L H2BC11 RPL27 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.92e-15 | 256 | 84 | 14 | 35777956 |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 TRIM60 | 5.74e-15 | 277 | 84 | 14 | 30745168 | |
| Pubmed | H2BC12L H2BC11 RPL27 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 KRBA2 H2BC20P ZNF318 H2BC19P UBXN1 NEB H2BC12 H2BC18 | 1.00e-14 | 844 | 84 | 20 | 25963833 | |
| Pubmed | 1.04e-14 | 55 | 84 | 9 | 9439656 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SART1 RPL27 SETD2 RBM25 H2BC15 H2BC14 H2BC9 CTCF LUC7L2 ZC3H13 DHX38 HMGXB4 SUPT16H SLTM ANKRD11 H2BC5 ZC3H18 ZNF318 IK BHLHE40 JMJD1C H2BC12 HELLS | 3.17e-14 | 1294 | 84 | 23 | 30804502 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 LUC7L2 SUPT16H RBM26 H2BC5 H2BC3 H2BC12 H2BC18 | 1.09e-13 | 425 | 84 | 15 | 21081503 | |
| Pubmed | SART1 H2BC11 RPL27 MYH3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 SHANK2 PYROXD1 CHD5 SUPT16H DNAJC21 H2BC5 H2BC3 KRBA2 ZNF318 NEB H2BC12 H2BC18 EPHA4 | 3.01e-13 | 1442 | 84 | 23 | 35575683 | |
| Pubmed | Gene-specific characterization of human histone H2B by electron capture dissociation. | 4.36e-13 | 6 | 84 | 5 | 16457587 | |
| Pubmed | Regulation of error-prone translesion synthesis by Spartan/C1orf124. | 1.65e-12 | 59 | 84 | 8 | 23254330 | |
| Pubmed | H2BC12L H2BC11 RPL27 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.92e-12 | 438 | 84 | 14 | 21630459 | |
| Pubmed | RPL27 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 SUPT16H H2BC5 H2BC3 H2BC18 | 3.06e-12 | 206 | 84 | 11 | 22174317 | |
| Pubmed | H2BC11 RPL27 SEPSECS H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF CHD5 SUPT16H H2BC5 PIP5K1A H2BC3 BUD13 PIP5K1B H2BC12 H2BC18 | 3.14e-12 | 1153 | 84 | 20 | 29845934 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | H2BC12L H2BC11 RPL27 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H H2BC5 H2BC3 H2BC12 H2BC18 | 2.69e-11 | 626 | 84 | 15 | 33644029 |
| Pubmed | 1.43e-10 | 14 | 84 | 5 | 10064132 | ||
| Pubmed | Endotoxin-neutralizing antimicrobial proteins of the human placenta. | 1.58e-10 | 5 | 84 | 4 | 11859126 | |
| Pubmed | Biochemical and antibacterial analysis of human wound and blister fluid. | 1.58e-10 | 5 | 84 | 4 | 8620898 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | SART1 RPL27 RBM25 H2BC9 LUC7L2 ZC3H13 CHD5 DHX38 SUPT16H SMARCA2 ZC3H18 IK H2BC12 HELLS | 2.08e-10 | 605 | 84 | 14 | 28977666 |
| Pubmed | SART1 UTP6 H2BC11 H2BC13 RBM25 CTCF ZC3H13 DHX38 SLTM SMARCA2 RBM6 ZC3H18 ZNF318 IK | 5.59e-10 | 653 | 84 | 14 | 22586326 | |
| Pubmed | Antimicrobial peptides in the first line defence of human colon mucosa. | 6.09e-10 | 18 | 84 | 5 | 12860195 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | SART1 H2BC11 RPL27 RBM25 H2BC4 H2BC21 LUC7L2 CHD5 SUPT16H SLTM DNAJC21 GABARAP RB1CC1 IK DENND2B H2BC12 | 9.40e-10 | 949 | 84 | 16 | 36574265 |
| Pubmed | 1.10e-09 | 7 | 84 | 4 | 15019208 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SART1 H2BC11 RPL27 H2BC13 RBM25 H2BC15 H2BC14 H2BC4 H2BC17 LUC7L2 ZC3H13 SMARCA2 H2BC5 H2BC3 H2BC12 | 1.73e-09 | 847 | 84 | 15 | 35235311 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | SART1 H2BC11 H2BC17 CTCF SUPT16H RBM26 H2BC5 PIP5K1A H2BC3 ZC3H18 H2BC12 | 3.04e-09 | 394 | 84 | 11 | 27248496 |
| Pubmed | 9.20e-09 | 247 | 84 | 9 | 30713523 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | SART1 UTP6 H2BC4 TLE3 DHX38 SUPT16H RBM26 H2BC3 ZC3H18 JMJD1C | 1.05e-08 | 341 | 84 | 10 | 32971831 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.23e-08 | 451 | 84 | 11 | 36168627 | |
| Pubmed | SART1 H2BC11 SETD2 RBM25 CTCF DHX38 SUPT16H RBM26 SLTM SMARCA2 ZC3H18 UBXN1 IK H2BC12 HELLS | 1.91e-08 | 1014 | 84 | 15 | 32416067 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 RBM26 H2BC5 H2BC3 UMPS H2BC12 H2BC18 | 2.38e-08 | 878 | 84 | 14 | 37223481 | |
| Pubmed | 7.66e-08 | 88 | 84 | 6 | 26318153 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | PKMYT1 CEP350 SART1 SETD2 RBM25 SHANK2 LUC7L2 TLE3 SUPT16H GABARAP RB1CC1 NEB | 1.12e-07 | 695 | 84 | 12 | 23602568 |
| Pubmed | 1.19e-07 | 19 | 84 | 4 | 16522924 | ||
| Pubmed | 1.73e-07 | 250 | 84 | 8 | 33536335 | ||
| Pubmed | 1.79e-07 | 251 | 84 | 8 | 31076518 | ||
| Pubmed | SART1 RPL27 RBM25 H2BC21 LUC7L2 ZC3H13 SUPT16H SLTM H2BC5 BUD13 ZC3H18 IK | 1.93e-07 | 731 | 84 | 12 | 29298432 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.35e-07 | 361 | 84 | 9 | 26167880 | |
| Pubmed | Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. | 2.70e-07 | 6 | 84 | 3 | 22967069 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SART1 UTP6 H2BC11 RPL27 RBM25 ZC3H13 CHD5 DHX38 SUPT16H SLTM DNAJC21 BUD13 ZC3H18 IK H2BC12 | 3.08e-07 | 1257 | 84 | 15 | 36526897 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SART1 SETD2 RBM25 TLE3 ZC3H13 SMARCA2 RBM6 BUD13 ZC3H18 ZNF318 RERE URGCP | 3.54e-07 | 774 | 84 | 12 | 15302935 |
| Pubmed | SART1 SETD2 RBM25 CTCF LUC7L2 CHD5 HMGXB4 SUPT16H SMARCA2 H2BC3 BUD13 ZC3H18 ZNF318 RERE | 4.43e-07 | 1116 | 84 | 14 | 31753913 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.45e-07 | 283 | 84 | 8 | 30585729 | |
| Pubmed | Characterization of the 55-kb mouse histone gene cluster on chromosome 3. | 4.72e-07 | 7 | 84 | 3 | 8858345 | |
| Pubmed | The activity-dependent histone variant H2BE modulates the life span of olfactory neurons. | 4.72e-07 | 7 | 84 | 3 | 23240083 | |
| Pubmed | H2BC12L SART1 H2BC11 RPL27 H2BC13 H2BC15 SUPT16H SLTM H2BC5 H2BC19P H2BC12 | 4.97e-07 | 652 | 84 | 11 | 31180492 | |
| Pubmed | SETD2 H2BC13 H2BC21 SHANK2 CTCF DHX38 HMGXB4 RBM26 SMARCA2 ANKRD11 RBM6 DNAJC21 BUD13 CEP131 ZNF318 IK | 5.14e-07 | 1497 | 84 | 16 | 31527615 | |
| Pubmed | 6.88e-07 | 205 | 84 | 7 | 27976729 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | SART1 RPL27 RBM25 H2BC15 CTCF LUC7L2 DHX38 SUPT16H RBM26 SLTM RBM6 IK JMJD1C | 7.12e-07 | 989 | 84 | 13 | 36424410 |
| Pubmed | 7.54e-07 | 8 | 84 | 3 | 9710638 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 7.77e-07 | 130 | 84 | 6 | 35545047 | |
| Pubmed | 8.14e-07 | 419 | 84 | 9 | 15635413 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CEP350 SART1 UTP6 RBM25 H2BC15 H2BC21 SUPT16H SLTM CEP131 ZNF318 RB1CC1 IK HELLS | 1.05e-06 | 1024 | 84 | 13 | 24711643 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.31e-06 | 444 | 84 | 9 | 34795231 | |
| Pubmed | CEP350 TLE3 DHX38 SUPT16H SLTM H2BC5 GABARAP H2BC3 ROBO1 CEP131 RB1CC1 IK HELLS | 1.37e-06 | 1049 | 84 | 13 | 27880917 | |
| Pubmed | Human histone gene organization: nonregular arrangement within a large cluster. | 1.57e-06 | 35 | 84 | 4 | 9119399 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | H2BC12L RPL27 H2BC13 H2BC15 H2BC14 H2BC9 LUC7L2 H2BC5 UMPS UBXN1 IK H2BC12 H2BC18 HELLS | 1.81e-06 | 1257 | 84 | 14 | 37317656 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SART1 RPL27 SETD2 RBM25 LUC7L2 ZC3H13 HMGXB4 SUPT16H SLTM RBM6 BUD13 ZC3H18 IK | 1.93e-06 | 1082 | 84 | 13 | 38697112 |
| Pubmed | 2.08e-06 | 242 | 84 | 7 | 34011540 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.29e-06 | 497 | 84 | 9 | 36774506 | |
| Pubmed | An 'equalized cDNA library' by the reassociation of short double-stranded cDNAs. | 3.82e-06 | 13 | 84 | 3 | 2216762 | |
| Pubmed | 3.82e-06 | 13 | 84 | 3 | 8858344 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SART1 RPL27 RBM25 LUC7L2 ZC3H13 DHX38 SUPT16H RBM26 SLTM RBM6 ZC3H18 | 3.91e-06 | 807 | 84 | 11 | 22681889 |
| Pubmed | 4.07e-06 | 268 | 84 | 7 | 33640491 | ||
| Pubmed | 4.67e-06 | 177 | 84 | 6 | 26206133 | ||
| Pubmed | 5.30e-06 | 103 | 84 | 5 | 32744500 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 5.60e-06 | 398 | 84 | 8 | 35016035 | |
| Pubmed | PI4P5-kinase Ialpha is required for efficient HIV-1 entry and infection of T cells. | 5.76e-06 | 2 | 84 | 2 | 18981107 | |
| Pubmed | A role for PtdIns(4,5)P2 and PIP5Kalpha in regulating stress-induced apoptosis. | 5.76e-06 | 2 | 84 | 2 | 16979564 | |
| Pubmed | Dissecting indirect genetic effects from peers in laboratory mice. | 5.76e-06 | 2 | 84 | 2 | 34311762 | |
| Pubmed | Type Ialpha phosphatidylinositol-4-phosphate 5-kinase mediates Rac-dependent actin assembly. | 5.76e-06 | 2 | 84 | 2 | 10679324 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 18772378 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 8611618 | ||
| Pubmed | Cloning of cDNAs encoding two isoforms of 68-kDa type I phosphatidylinositol-4-phosphate 5-kinase. | 5.76e-06 | 2 | 84 | 2 | 8798574 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 32885250 | ||
| Pubmed | Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia. | 5.76e-06 | 2 | 84 | 2 | 10910076 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21270258 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15728183 | ||
| Pubmed | Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes. | 5.76e-06 | 2 | 84 | 2 | 10187762 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 38520674 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 8955136 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 5.79e-06 | 533 | 84 | 9 | 30554943 | |
| Pubmed | SART1 RPL27 H2BC13 RBM25 CTCF LUC7L2 ZC3H13 DHX38 SLTM ZC3H18 IK | 6.17e-06 | 847 | 84 | 11 | 35850772 | |
| Interaction | CYLC1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 SLTM H2BC5 H2BC3 H2BC12 H2BC18 | 4.73e-22 | 20 | 83 | 11 | int:CYLC1 |
| Interaction | CDK5R2 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.77e-21 | 23 | 83 | 11 | int:CDK5R2 |
| Interaction | TNN interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.77e-21 | 23 | 83 | 11 | int:TNN |
| Interaction | H2BC4 interactions | CEP350 H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 CHD5 SLTM SMARCA2 ANKRD11 H2BC5 H2BC3 ZC3H18 NEB JMJD1C H2BC12 H2BC18 | 7.43e-19 | 259 | 83 | 19 | int:H2BC4 |
| Interaction | DUOX2 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.25e-17 | 30 | 83 | 10 | int:DUOX2 |
| Interaction | HMGN3 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.87e-17 | 64 | 83 | 12 | int:HMGN3 |
| Interaction | TEX35 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.60e-16 | 57 | 83 | 11 | int:TEX35 |
| Interaction | H2AC7 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ZC3H18 H2BC12 H2BC18 | 4.88e-16 | 107 | 83 | 13 | int:H2AC7 |
| Interaction | SMC5 interactions | H2BC12L SART1 RPL27 SETD2 H2BC13 RBM25 H2BC15 H2BC14 H2BC9 CTCF ZC3H13 HMGXB4 SUPT16H RBM26 SLTM ANKRD11 RBM6 H2BC5 BUD13 ZC3H18 ZNF318 IK CWC25 JMJD1C H2BC12 H2BC18 HELLS | 1.53e-15 | 1000 | 83 | 27 | int:SMC5 |
| Interaction | H2AJ interactions | H2BC11 H2BC13 RBM25 H2BC15 H2BC17 H2BC21 SUPT16H H2BC5 H2BC3 BUD13 CWC25 H2BC12 H2BC18 | 4.81e-15 | 127 | 83 | 13 | int:H2AJ |
| Interaction | HMGN4 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 SUPT16H H2BC5 H2BC3 H2BC12 H2BC18 | 8.17e-15 | 100 | 83 | 12 | int:HMGN4 |
| Interaction | H2BC12 interactions | CEP350 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CHD5 SLTM ANKRD11 H2BC5 H2BC3 NEB H2BC12 H2BC18 | 1.49e-14 | 322 | 83 | 17 | int:H2BC12 |
| Interaction | H2AC14 interactions | PKMYT1 H2BC11 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 DNAJC21 H2BC5 H2BC3 H2BC20P H2BC12 H2BC18 | 2.52e-14 | 144 | 83 | 13 | int:H2AC14 |
| Interaction | FAM47B interactions | 2.61e-14 | 13 | 83 | 7 | int:FAM47B | |
| Interaction | H2AC18 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H H2BC5 H2BC3 NEB H2BC12 H2BC18 | 3.60e-14 | 148 | 83 | 13 | int:H2AC18 |
| Interaction | H2AC25 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.24e-14 | 84 | 83 | 11 | int:H2AC25 |
| Interaction | DPPA2 interactions | H2BC11 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.38e-14 | 40 | 83 | 9 | int:DPPA2 |
| Interaction | JPH2 interactions | 5.98e-14 | 25 | 83 | 8 | int:JPH2 | |
| Interaction | H3C1 interactions | H2BC11 SETD2 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF LUC7L2 TLE3 DHX38 HMGXB4 SUPT16H SMARCA2 H2BC5 H2BC3 BIN2 IK NEB JMJD1C H2BC12 H2BC18 HELLS | 1.12e-13 | 901 | 83 | 24 | int:H3C1 |
| Interaction | ZNF474 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 1.38e-13 | 44 | 83 | 9 | int:ZNF474 |
| Interaction | LOC102724334 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.93e-13 | 134 | 83 | 12 | int:LOC102724334 |
| Interaction | HCLS1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.02e-13 | 71 | 83 | 10 | int:HCLS1 |
| Interaction | H2BC14 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.07e-13 | 100 | 83 | 11 | int:H2BC14 |
| Interaction | H2BC1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H SMARCA2 H2BC5 H2BC3 H2BC12 H2BC18 | 3.95e-13 | 178 | 83 | 13 | int:H2BC1 |
| Interaction | H2BC17 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.98e-13 | 140 | 83 | 12 | int:H2BC17 |
| Interaction | H2BC26 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H H2BC5 H2BC3 H2BC12 H2BC18 | 5.65e-13 | 183 | 83 | 13 | int:H2BC26 |
| Interaction | H2BC11 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H H2BC5 H2BC3 H2BC12 H2BC18 | 6.96e-13 | 186 | 83 | 13 | int:H2BC11 |
| Interaction | H2BC15 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 6.98e-13 | 144 | 83 | 12 | int:H2BC15 |
| Interaction | ADARB1 interactions | H2BC11 RPL27 H2BC13 RBM25 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF CHD5 RBM26 H2BC5 H2BC3 BUD13 H2BC12 H2BC18 | 1.09e-12 | 489 | 83 | 18 | int:ADARB1 |
| Interaction | TTN interactions | RPL27 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 MYOM1 TLE3 H2BC5 GABARAP UBXN1 NEB H2BC12 RYR1 H2BC18 | 1.29e-12 | 299 | 83 | 15 | int:TTN |
| Interaction | H2AC4 interactions | SART1 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF SUPT16H RBM26 H2BC5 PIP5K1A H2BC3 H2BC20P H2BC12 H2BC18 | 1.93e-12 | 506 | 83 | 18 | int:H2AC4 |
| Interaction | H2AZ1 interactions | H2BC11 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 CTCF HMGXB4 SUPT16H H2BC5 H2BC3 H2BC20P ZC3H18 JMJD1C H2BC12 H2BC18 | 2.13e-12 | 371 | 83 | 16 | int:H2AZ1 |
| Interaction | H2AX interactions | SART1 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF SUPT16H SMARCA2 H2BC5 H2BC3 H2BC20P ZC3H18 NEB H2BC12 H2BC18 | 2.68e-12 | 593 | 83 | 19 | int:H2AX |
| Interaction | H2BC13 interactions | CEP350 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.28e-12 | 210 | 83 | 13 | int:H2BC13 |
| Interaction | HMGN2 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ZC3H18 H2BC12 H2BC18 | 6.63e-12 | 222 | 83 | 13 | int:HMGN2 |
| Interaction | H2BC18 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 9.95e-12 | 180 | 83 | 12 | int:H2BC18 |
| Interaction | H2AC6 interactions | H2BC11 H2BC13 H2BC15 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.03e-11 | 100 | 83 | 10 | int:H2AC6 |
| Interaction | PCLO interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 1.16e-11 | 70 | 83 | 9 | int:PCLO |
| Interaction | H2AC1 interactions | 1.32e-11 | 71 | 83 | 9 | int:H2AC1 | |
| Interaction | DHX8 interactions | SART1 SETD2 RBM25 LUC7L2 ZC3H13 DHX38 RBM26 SLTM RBM6 BUD13 ZC3H18 ZNF318 IK CWC25 | 1.42e-11 | 292 | 83 | 14 | int:DHX8 |
| Interaction | IGSF8 interactions | H2BC11 RPL27 MYH3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 SUPT16H H2BC5 H2BC3 H2BC12 H2BC18 | 1.68e-11 | 239 | 83 | 13 | int:IGSF8 |
| Interaction | H2AC13 interactions | H2BC11 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.20e-11 | 75 | 83 | 9 | int:H2AC13 |
| Interaction | CD81 interactions | H2BC11 RPL27 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 LUC7L2 SUPT16H H2BC5 H2BC3 UBXN1 H2BC12 H2BC18 | 2.33e-11 | 303 | 83 | 14 | int:CD81 |
| Interaction | DHX40 interactions | SETD2 H2BC4 ZC3H13 DHX38 SUPT16H SLTM ANKRD11 RBM6 ZC3H18 ZNF318 IK CWC25 H2BC12 | 2.81e-11 | 249 | 83 | 13 | int:DHX40 |
| Interaction | ICAM1 interactions | H2BC11 RPL27 MYH3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 SUPT16H H2BC5 H2BC3 H2BC12 H2BC18 | 3.26e-11 | 252 | 83 | 13 | int:ICAM1 |
| Interaction | H2BC9 interactions | CEP350 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H DNAJC21 H2BC5 H2BC3 NEB H2BC12 H2BC18 | 3.37e-11 | 446 | 83 | 16 | int:H2BC9 |
| Interaction | H2BC21 interactions | PKMYT1 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 HMGXB4 SUPT16H DNAJC21 H2BC5 H2BC3 ZC3H18 NEB JMJD1C H2BC12 H2BC18 | 4.26e-11 | 696 | 83 | 19 | int:H2BC21 |
| Interaction | SFMBT2 interactions | 4.81e-11 | 32 | 83 | 7 | int:SFMBT2 | |
| Interaction | H2AC12 interactions | H2BC11 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.46e-11 | 118 | 83 | 10 | int:H2AC12 |
| Interaction | H2BC5 interactions | CEP350 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ZC3H18 H2BC12 H2BC18 | 7.53e-11 | 331 | 83 | 14 | int:H2BC5 |
| Interaction | H2BC3 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H H2BC5 PIP5K1A H2BC3 ZC3H18 H2BC12 H2BC18 | 9.88e-11 | 406 | 83 | 15 | int:H2BC3 |
| Interaction | MCM5 interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 1.58e-10 | 420 | 83 | 15 | int:MCM5 |
| Interaction | PINK1 interactions | H2BC12L SART1 H2BC11 RPL27 H2BC13 RBM25 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 ZC3H13 SUPT16H H2BC5 H2BC3 RB1CC1 H2BC12 H2BC18 | 2.42e-10 | 679 | 83 | 18 | int:PINK1 |
| Interaction | H2AC11 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 NEB H2BC12 H2BC18 | 4.13e-10 | 248 | 83 | 12 | int:H2AC11 |
| Interaction | TMA7 interactions | 7.30e-10 | 46 | 83 | 7 | int:TMA7 | |
| Interaction | DDX23 interactions | SART1 SETD2 RBM25 ZC3H13 DHX38 SUPT16H RBM26 SLTM ANKRD11 RBM6 BUD13 ZC3H18 IK CWC25 HELLS | 9.99e-10 | 480 | 83 | 15 | int:DDX23 |
| Interaction | HMGA1 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 ROBO1 H2BC20P ZC3H18 H2BC12 H2BC18 | 1.63e-09 | 419 | 83 | 14 | int:HMGA1 |
| Interaction | UBA52 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 NLRP1 NEB H2BC12 H2BC18 | 2.80e-09 | 437 | 83 | 14 | int:UBA52 |
| Interaction | PDS5B interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.13e-09 | 178 | 83 | 10 | int:PDS5B |
| Interaction | MAP1B interactions | H2BC12L H2BC11 RPL27 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF H2BC5 H2BC3 H2BC12 H2BC18 | 4.82e-09 | 539 | 83 | 15 | int:MAP1B |
| Interaction | RIOK1 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 LUC7L2 SUPT16H RBM26 H2BC5 H2BC3 H2BC12 H2BC18 | 8.44e-09 | 562 | 83 | 15 | int:RIOK1 |
| Interaction | KNOP1 interactions | RPL27 H2BC13 H2BC15 H2BC4 H2BC17 SLTM H2BC5 H2BC3 ZC3H18 H2BC12 H2BC18 | 1.51e-08 | 272 | 83 | 11 | int:KNOP1 |
| Interaction | TMEM196 interactions | 1.85e-08 | 8 | 83 | 4 | int:TMEM196 | |
| Interaction | TOP2A interactions | H2BC11 RPL27 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 CTCF DNAJC21 H2BC5 ZC3H18 KMT2E H2BC12 H2BC18 | 2.52e-08 | 520 | 83 | 14 | int:TOP2A |
| Interaction | HEXIM1 interactions | SART1 H2BC11 RPL27 SEPSECS H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CHD5 SUPT16H H2BC5 PIP5K1A H2BC3 H2BC12 H2BC18 | 2.53e-08 | 913 | 83 | 18 | int:HEXIM1 |
| Interaction | MEN1 interactions | SART1 UTP6 RPL27 H2BC13 RBM25 H2BC4 H2BC21 CTCF TLE3 ZC3H13 DHX38 SUPT16H RBM26 SLTM H2BC3 ZC3H18 RERE IK JMJD1C | 2.75e-08 | 1029 | 83 | 19 | int:MEN1 |
| Interaction | PSMD14 interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 TRIM60 | 2.98e-08 | 527 | 83 | 14 | int:PSMD14 |
| Interaction | H2AZ2 interactions | 3.04e-08 | 168 | 83 | 9 | int:H2AZ2 | |
| Interaction | H3-4 interactions | H2BC11 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 CHD5 HMGXB4 H2BC5 H2BC20P H2BC12 | 3.50e-08 | 448 | 83 | 13 | int:H3-4 |
| Interaction | RPS27A interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ZC3H18 NEB H2BC12 H2BC18 | 3.68e-08 | 536 | 83 | 14 | int:RPS27A |
| Interaction | CHD4 interactions | SART1 RPL27 H2BC13 RBM25 H2BC9 H2BC21 LUC7L2 CHD5 HMGXB4 SUPT16H SMARCA2 H2BC5 H2BC3 H2BC20P ZC3H18 IK H2BC12 HELLS | 3.82e-08 | 938 | 83 | 18 | int:CHD4 |
| Interaction | MCM2 interactions | H2BC12L H2BC11 RPL27 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H H2BC5 H2BC3 KRBA2 ZNF318 UBXN1 NEB H2BC12 H2BC18 | 6.00e-08 | 1081 | 83 | 19 | int:MCM2 |
| Interaction | CHD3 interactions | SART1 RPL27 RBM25 H2BC9 LUC7L2 ZC3H13 CHD5 DHX38 HMGXB4 SUPT16H SMARCA2 H2BC3 ZC3H18 IK BHLHE40 H2BC12 | 6.61e-08 | 757 | 83 | 16 | int:CHD3 |
| Interaction | H2AC20 interactions | H2BC11 H2BC15 H2BC9 H2BC17 H2BC21 CTCF SUPT16H H2BC5 H2BC3 H2BC12 H2BC18 | 7.96e-08 | 320 | 83 | 11 | int:H2AC20 |
| Interaction | ZC3H18 interactions | SART1 RPL27 RBM25 H2BC4 H2BC21 CTCF LUC7L2 ZC3H13 SUPT16H SLTM RBM6 H2BC5 PIP5K1A H2BC3 BUD13 ZC3H18 IK | 8.42e-08 | 877 | 83 | 17 | int:ZC3H18 |
| Interaction | LARP7 interactions | H2BC11 RPL27 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF LUC7L2 DHX38 H2BC5 PIP5K1A H2BC3 BUD13 PIP5K1B H2BC12 H2BC18 | 9.48e-08 | 1113 | 83 | 19 | int:LARP7 |
| Interaction | PRKCB interactions | H2BC11 DLGAP1 H2BC13 H2BC15 H2BC14 H2BC21 H2BC5 H2BC3 UBXN1 H2BC12 | 9.54e-08 | 255 | 83 | 10 | int:PRKCB |
| Interaction | ADAMTS12 interactions | 1.00e-07 | 55 | 83 | 6 | int:ADAMTS12 | |
| Interaction | ELK4 interactions | 1.03e-07 | 92 | 83 | 7 | int:ELK4 | |
| Interaction | EZH1 interactions | 1.03e-07 | 92 | 83 | 7 | int:EZH1 | |
| Interaction | H3C15 interactions | H2BC11 H2BC13 H2BC9 H2BC4 H2BC21 SUPT16H H2BC5 ZC3H18 H2BC12 | 1.82e-07 | 207 | 83 | 9 | int:H3C15 |
| Interaction | SUPT16H interactions | H2BC11 RBM25 H2BC9 H2BC21 ZC3H13 DHX38 SUPT16H SMARCA2 H2BC3 ZC3H18 IK NEB | 2.53e-07 | 442 | 83 | 12 | int:SUPT16H |
| Interaction | ANKRD50 interactions | 3.10e-07 | 108 | 83 | 7 | int:ANKRD50 | |
| Interaction | SIRT7 interactions | SART1 UTP6 H2BC11 H2BC13 RBM25 H2BC21 CTCF ZC3H13 DHX38 SLTM SMARCA2 RBM6 ZC3H18 ZNF318 IK | 3.30e-07 | 744 | 83 | 15 | int:SIRT7 |
| Interaction | YY1 interactions | SART1 H2BC13 RBM25 H2BC14 H2BC9 H2BC4 CTCF HMGXB4 H2BC5 KMT2E H2BC12 H2BC18 | 3.37e-07 | 454 | 83 | 12 | int:YY1 |
| Interaction | MEPCE interactions | SART1 H2BC11 RPL27 H2BC13 RBM25 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 LUC7L2 H2BC5 H2BC3 H2BC12 H2BC18 | 3.67e-07 | 859 | 83 | 16 | int:MEPCE |
| Interaction | H3-5 interactions | 4.48e-07 | 114 | 83 | 7 | int:H3-5 | |
| Interaction | HMGN1 interactions | 4.58e-07 | 168 | 83 | 8 | int:HMGN1 | |
| Interaction | DOK2 interactions | 5.05e-07 | 116 | 83 | 7 | int:DOK2 | |
| Interaction | H2AC21 interactions | 5.13e-07 | 234 | 83 | 9 | int:H2AC21 | |
| Interaction | PWWP2A interactions | 7.06e-07 | 76 | 83 | 6 | int:PWWP2A | |
| Interaction | BTF3 interactions | H2BC12L H2BC11 RPL27 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SUPT16H H2BC5 H2BC3 H2BC12 H2BC18 | 8.12e-07 | 799 | 83 | 15 | int:BTF3 |
| Interaction | BRD3 interactions | SART1 RBM25 CTCF LUC7L2 DHX38 HMGXB4 SUPT16H SMARCA2 H2BC3 BUD13 H2BC18 HELLS | 8.23e-07 | 494 | 83 | 12 | int:BRD3 |
| Interaction | ENY2 interactions | 9.89e-07 | 186 | 83 | 8 | int:ENY2 | |
| Interaction | SERBP1 interactions | H2BC12L H2BC11 RPL27 H2BC13 RBM25 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 CTCF ZC3H13 RBM26 H2BC5 PIP5K1A H2BC3 UMPS UBXN1 H2BC12 H2BC18 | 1.02e-06 | 1432 | 83 | 20 | int:SERBP1 |
| Interaction | USF3 interactions | 1.23e-06 | 20 | 83 | 4 | int:USF3 | |
| Interaction | SRPK2 interactions | SART1 SETD2 CTCF LUC7L2 ZC3H13 HMGXB4 SUPT16H RBM26 SLTM GABARAP BUD13 ZC3H18 JMJD1C H2BC12 | 1.25e-06 | 717 | 83 | 14 | int:SRPK2 |
| Interaction | TOP2B interactions | 1.49e-06 | 266 | 83 | 9 | int:TOP2B | |
| Interaction | ATRX interactions | 1.54e-06 | 267 | 83 | 9 | int:ATRX | |
| Interaction | POLR2A interactions | H2BC11 SETD2 H2BC13 H2BC9 H2BC4 H2BC21 CTCF ZC3H13 SUPT16H SMARCA2 H2BC5 H2BC12 | 1.93e-06 | 536 | 83 | 12 | int:POLR2A |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 2.04e-09 | 378 | 84 | 10 | chr6p22 |
| Cytoband | 6p22.1 | 2.62e-07 | 142 | 84 | 6 | 6p22.1 | |
| Cytoband | 1q21.2 | 9.23e-06 | 71 | 84 | 4 | 1q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 8.99e-04 | 404 | 84 | 5 | chr1q21 | |
| Cytoband | 18p11.31 | 1.30e-03 | 29 | 84 | 2 | 18p11.31 | |
| Cytoband | 17p13.1 | 1.36e-03 | 118 | 84 | 3 | 17p13.1 | |
| Cytoband | 7p22.1 | 3.39e-03 | 47 | 84 | 2 | 7p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 3.81e-03 | 346 | 84 | 4 | chr17p13 | |
| GeneFamily | Histones | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC20P H2BC19P H2BC12 H2BC18 | 4.84e-21 | 116 | 55 | 15 | 864 |
| GeneFamily | Zinc fingers CCCH-type | 1.63e-04 | 35 | 55 | 3 | 73 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.23e-03 | 181 | 55 | 4 | 694 | |
| GeneFamily | RNA binding motif containing | 3.99e-03 | 213 | 55 | 4 | 725 | |
| GeneFamily | Autophagy related | 4.52e-03 | 33 | 55 | 2 | 1022 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.79e-03 | 34 | 55 | 2 | 487 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | PKMYT1 SNRNP25 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 OXCT1 H2BC4 CTCF HMGXB4 SASS6 H2BC3 BUD13 UMPS CEP131 H2BC18 HELLS | 6.69e-10 | 939 | 83 | 18 | M45768 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | PKMYT1 SNRNP25 H2BC11 H2BC13 H2BC15 H2BC9 OXCT1 H2BC4 CTCF HMGXB4 SASS6 H2BC3 BUD13 H2BC18 HELLS | 4.36e-09 | 694 | 83 | 15 | M45767 |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | H2BC11 H2BC13 H2BC15 H2BC14 H2BC4 H2BC21 H2BC5 JMJD1C H2BC12 | 1.48e-08 | 200 | 83 | 9 | M9952 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | H2BC12L H2BC11 SEPSECS H2BC13 RBM25 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 RBM26 H2BC5 H2BC3 H2BC12 | 1.24e-07 | 768 | 83 | 14 | M6444 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | PKMYT1 SNRNP25 H2BC11 H2BC15 H2BC9 H2BC4 SASS6 H2BC3 PIP5K1B H2BC18 HELLS | 1.80e-07 | 450 | 83 | 11 | M45747 |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN | 2.32e-07 | 199 | 83 | 8 | M9954 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | PKMYT1 SNRNP25 H2BC11 H2BC15 H2BC9 OXCT1 H2BC4 PYROXD1 PRELID2 HMGXB4 SASS6 DNAJC21 BUD13 UMPS CEP131 ZC3H18 H2BC18 HELLS | 3.87e-07 | 1423 | 83 | 18 | M45722 |
| Coexpression | HASLINGER_B_CLL_WITH_6Q21_DELETION | 6.55e-07 | 22 | 83 | 4 | M7362 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.46e-06 | 111 | 83 | 6 | MM705 | |
| Coexpression | FISCHER_DREAM_TARGETS | PKMYT1 SNRNP25 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 CTCF HMGXB4 SUPT16H SASS6 BHLHE40 HELLS | 2.00e-06 | 969 | 83 | 14 | M149 |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 3.12e-06 | 197 | 83 | 7 | M3193 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | PKMYT1 SNRNP25 H2BC15 H2BC9 OXCT1 CTCF HMGXB4 SUPT16H SASS6 DNAJC21 H2BC3 BUD13 UMPS CEP131 H2BC18 HELLS | 4.99e-06 | 1363 | 83 | 16 | M45782 |
| Coexpression | BENPORATH_MYC_MAX_TARGETS | H2BC12L H2BC11 RPL27 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 TLE3 SUPT16H GABARAP UBXN1 | 5.81e-06 | 775 | 83 | 12 | M17753 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.37e-05 | 96 | 83 | 5 | M1683 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | H2BC11 H2BC13 H2BC9 H2BC4 H2BC17 SASS6 H2BC5 H2BC3 H2BC12 H2BC18 HELLS | 1.54e-05 | 714 | 83 | 11 | M1744 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | PKMYT1 H2BC11 H2BC15 H2BC14 H2BC9 HMGXB4 DNAJC21 H2BC3 HELLS | 2.06e-05 | 478 | 83 | 9 | M45785 |
| Coexpression | DANG_BOUND_BY_MYC | H2BC12L H2BC11 RPL27 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 TLE3 SUPT16H GABARAP UBXN1 | 2.78e-05 | 1061 | 83 | 13 | M15774 |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN | 3.88e-05 | 119 | 83 | 5 | M8817 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN | 3.90e-05 | 197 | 83 | 6 | M5385 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 4.01e-05 | 198 | 83 | 6 | MM17083 | |
| Coexpression | FISCHER_G1_S_CELL_CYCLE | 4.24e-05 | 200 | 83 | 6 | M107 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN | 4.24e-05 | 200 | 83 | 6 | M5019 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 6.84e-05 | 432 | 83 | 8 | M41149 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CEP350 SETD2 CTCF HMGXB4 SMARCA2 RBM6 PIP5K1A RB1CC1 BHLHE40 DENND2B EPHA4 | 8.00e-05 | 856 | 83 | 11 | M4500 |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | UTP6 H2BC11 H2BC13 H2BC4 H2BC17 TLE3 DHX38 RBM6 H2BC5 GABARAP TSHZ1 H2BC12 H2BC18 | 1.34e-04 | 1239 | 83 | 13 | M1743 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.94e-04 | 90 | 83 | 4 | M39250 | |
| Coexpression | DESCARTES_FETAL_EYE_SKELETAL_MUSCLE_CELLS | 2.09e-04 | 170 | 83 | 5 | M40176 | |
| Coexpression | GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN | 2.20e-04 | 172 | 83 | 5 | M6345 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CEP350 RPL27 SETD2 CTCF RBM26 SMARCA2 ANKRD11 NLRP1 BIN2 RB1CC1 IK KMT2E BHLHE40 JMJD1C | 2.32e-04 | 1492 | 83 | 14 | M40023 |
| Coexpression | STK33_SKM_UP | 2.62e-04 | 279 | 83 | 6 | M2857 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | SEPSECS H2BC4 LUC7L2 HMGXB4 RBM26 RB1CC1 CWC25 BHLHE40 JMJD1C | 3.00e-04 | 680 | 83 | 9 | M41089 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 3.00e-04 | 680 | 83 | 9 | MM456 | |
| Coexpression | YAGI_AML_WITH_INV_16_TRANSLOCATION | 3.30e-04 | 411 | 83 | 7 | M1047 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 3.60e-04 | 417 | 83 | 7 | M39224 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP | 3.93e-04 | 195 | 83 | 5 | M3184 | |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 4.02e-04 | 196 | 83 | 5 | M3243 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN | 4.02e-04 | 196 | 83 | 5 | M6126 | |
| Coexpression | GSE3982_MAC_VS_BCELL_DN | 4.12e-04 | 197 | 83 | 5 | M5495 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 4.31e-04 | 199 | 83 | 5 | M9420 | |
| Coexpression | GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN | 4.31e-04 | 199 | 83 | 5 | M7667 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH1_UP | 4.31e-04 | 199 | 83 | 5 | M5564 | |
| Coexpression | GSE3982_MAC_VS_TH1_DN | 4.31e-04 | 199 | 83 | 5 | M5511 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | 4.31e-04 | 199 | 83 | 5 | M5486 | |
| Coexpression | GSE3982_MAST_CELL_VS_MAC_UP | 4.31e-04 | 199 | 83 | 5 | M5429 | |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 4.31e-04 | 199 | 83 | 5 | M7374 | |
| Coexpression | GSE27786_NKCELL_VS_NEUTROPHIL_UP | 4.41e-04 | 200 | 83 | 5 | M4858 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP | 4.41e-04 | 200 | 83 | 5 | M7975 | |
| Coexpression | HALLMARK_MYOGENESIS | 4.41e-04 | 200 | 83 | 5 | M5909 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 4.41e-04 | 200 | 83 | 5 | M7839 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP | 4.41e-04 | 200 | 83 | 5 | M5416 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TREG_DN | 4.41e-04 | 200 | 83 | 5 | M5738 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN | 4.41e-04 | 200 | 83 | 5 | M8745 | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | 2.14e-09 | 32 | 81 | 6 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | 8.91e-09 | 70 | 81 | 7 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K1 | 2.58e-08 | 125 | 81 | 8 | facebase_RNAseq_e9.5_MandArch_2500_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | 3.55e-08 | 50 | 81 | 6 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | 2.09e-07 | 110 | 81 | 7 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | 3.26e-07 | 72 | 81 | 6 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K2 | 1.95e-06 | 54 | 81 | 5 | facebase_RNAseq_e9.5_FaceMes_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | 2.32e-06 | 157 | 81 | 7 | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | 2.79e-06 | 58 | 81 | 5 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | 2.86e-06 | 162 | 81 | 7 | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | RBM25 CTCF LUC7L2 TLE3 ZC3H13 HMGXB4 RBM26 SMARCA2 ANKRD11 PIP5K1A KMT2E JMJD1C HELLS | 9.97e-06 | 801 | 81 | 13 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | UTP6 RBM25 CTCF LUC7L2 ZC3H13 HMGXB4 RBM26 ANKRD11 RBM6 PIP5K1A ZNF318 KMT2E HELLS | 1.07e-05 | 806 | 81 | 13 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | 2.17e-05 | 43 | 81 | 4 | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | RBM25 LUC7L2 ZC3H13 HMGXB4 RBM26 DNAJC21 PIP5K1A ZNF318 RB1CC1 KMT2E JMJD1C HELLS | 3.64e-05 | 776 | 81 | 12 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | RBM25 LUC7L2 TLE3 ZC3H13 HMGXB4 RBM26 SMARCA2 ANKRD11 PIP5K1A KMT2E JMJD1C HELLS | 4.33e-05 | 790 | 81 | 12 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | RBM25 LUC7L2 ZC3H13 HMGXB4 RBM26 ANKRD11 DNAJC21 PIP5K1A ZNF318 KMT2E RYR1 HELLS | 4.60e-05 | 795 | 81 | 12 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | 4.63e-05 | 52 | 81 | 4 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | UTP6 RBM25 LUC7L2 TLE3 ZC3H13 HMGXB4 RBM26 PIP5K1A ROBO1 KMT2E JMJD1C HELLS | 5.85e-05 | 815 | 81 | 12 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BCLAF3 CEP350 RBM25 OXCT1 SHANK2 PYROXD1 ZC3H13 SUPT16H RBM26 SLTM SASS6 DNAJC21 NLRP1 H2BC18 HELLS | 7.17e-05 | 1257 | 81 | 15 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#3 | 7.40e-05 | 268 | 81 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | PKMYT1 SNRNP25 H2BC11 H2BC13 H2BC15 H2BC14 H2BC17 PRELID2 TLE3 H2BC5 H2BC3 UMPS NLRP1 H2BC12 H2BC18 HELLS | 8.44e-05 | 1429 | 81 | 16 | facebase_RNAseq_e8.5_ParaxMesoderm_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500_K1 | 1.48e-04 | 402 | 81 | 8 | facebase_RNAseq_e10.5_OlfacPit_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | H2BC13 H2BC15 H2BC14 PRELID2 ZC3H13 SUPT16H RBM26 SLTM DNAJC21 H2BC5 UMPS NLRP1 H2BC12 H2BC18 HELLS | 1.55e-04 | 1347 | 81 | 15 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | LUC7L2 ZC3H13 HMGXB4 RBM26 ANKRD11 DNAJC21 ZNF318 RB1CC1 NEB KMT2E HELLS | 1.74e-04 | 778 | 81 | 11 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | RBM25 LUC7L2 ZC3H13 HMGXB4 RBM26 SMARCA2 ANKRD11 KMT2E BHLHE40 JMJD1C HELLS | 2.19e-04 | 799 | 81 | 11 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 2.49e-04 | 80 | 81 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K4 | PKMYT1 H2BC11 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC3 UMPS NLRP1 H2BC12 H2BC18 HELLS | 3.16e-04 | 1125 | 81 | 13 | facebase_RNAseq_e9.5_MaxArch_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BCLAF3 CEP350 RBM25 OXCT1 SHANK2 PYROXD1 ZC3H13 SUPT16H RBM26 SLTM SASS6 DNAJC21 NLRP1 H2BC18 HELLS | 3.67e-04 | 1459 | 81 | 15 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 NLRP1 TSHZ1 BHLHE40 H2BC12 | 4.36e-04 | 727 | 81 | 10 | PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1 | 5.83e-04 | 376 | 81 | 7 | GSM538418_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | H2BC11 H2BC13 H2BC15 H2BC14 H2BC17 PRELID2 H2BC5 H2BC3 NLRP1 H2BC12 H2BC18 EPHA4 HELLS | 5.92e-04 | 1202 | 81 | 13 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.43e-04 | 275 | 81 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.43e-04 | 275 | 81 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.63e-04 | 182 | 81 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 7.79e-04 | 395 | 81 | 7 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | Stem Cells, SC.MPP34F.BM, Lineage- cKit+ Sca-1+ flk2+ CD34+, Bone marrow, avg-2 | 8.51e-04 | 401 | 81 | 7 | GSM791110_500 | |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | 8.51e-04 | 401 | 81 | 7 | GSM791108_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 8.76e-04 | 403 | 81 | 7 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | bone marrow | 8.79e-04 | 292 | 81 | 6 | bone marrow | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | MYH3 RBM25 MYOM1 LUC7L2 ZC3H13 HMGXB4 SMARCA2 ANKRD11 KMT2E HELLS | 8.87e-04 | 797 | 81 | 10 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | B cells, MLP.BM, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Bone marrow, avg-2 | 8.89e-04 | 404 | 81 | 7 | GSM791129_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 9.15e-04 | 406 | 81 | 7 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | RBM25 LUC7L2 ZC3H13 HMGXB4 RBM26 ANKRD11 PIP5K1A KMT2E JMJD1C HELLS | 9.47e-04 | 804 | 81 | 10 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.01e-03 | 413 | 81 | 7 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.01e-03 | 300 | 81 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K1 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 1.08e-03 | 418 | 81 | 7 | GSM538350_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 1.10e-03 | 419 | 81 | 7 | GSM538348_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500 | PKMYT1 BCLAF3 H2BC11 H2BC13 H2BC15 H2BC14 H2BC17 DNAJC21 H2BC5 H2BC3 NLRP1 TSHZ1 H2BC12 H2BC18 | 1.11e-03 | 1453 | 81 | 14 | facebase_RNAseq_e10.5_OlfacPit_2500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.38e-03 | 126 | 81 | 4 | gudmap_developingGonad_e14.5_ ovary_1000_k2 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.08e-08 | 158 | 84 | 7 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 8.21e-08 | 193 | 84 | 7 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.81e-08 | 195 | 84 | 7 | 027075e9c62b5754a014a9d1393e1b0f5ae42e41 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid-Megakaryocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.81e-08 | 195 | 84 | 7 | 1bcc0c8b1281396b1433ce5a2ec8681de47ce9ad | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.12e-08 | 196 | 84 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 9.44e-08 | 197 | 84 | 7 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.44e-08 | 197 | 84 | 7 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.44e-08 | 197 | 84 | 7 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.44e-08 | 197 | 84 | 7 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 9.78e-08 | 198 | 84 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-07 | 199 | 84 | 7 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.01e-07 | 199 | 84 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-07 | 200 | 84 | 7 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | Control-Lymphocyte-B-Plasmablast|Control / Disease, Lineage and Cell Type | 6.40e-07 | 162 | 84 | 6 | 67b32c40cc180c5ebbfd901a417b5be469500110 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-07 | 174 | 84 | 6 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-07 | 174 | 84 | 6 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|tumor_Lung / Location, Cell class and cell subclass | 1.11e-06 | 178 | 84 | 6 | c57f92e57548638f1627dc7d313137f406dbecff | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.18e-06 | 180 | 84 | 6 | 1be264962fd4ed0bb59f9b8a6956c4239ca32e05 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-06 | 180 | 84 | 6 | 5568063c2518fadb638e665635061ec10d00fb6a | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 181 | 84 | 6 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 181 | 84 | 6 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | COVID-19_Mild|World / Disease Group and Platelet Clusters | 1.26e-06 | 182 | 84 | 6 | 90c61e10c7860bfba6ccfe6f37671c8924637f7b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 186 | 84 | 6 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-06 | 186 | 84 | 6 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | B_cells-Plasmablasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.57e-06 | 189 | 84 | 6 | 87cb7b6ba9fd57100d68e6eaeecd1ac6ab22d1c6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.72e-06 | 192 | 84 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.77e-06 | 193 | 84 | 6 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 1.88e-06 | 195 | 84 | 6 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-06 | 195 | 84 | 6 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-06 | 197 | 84 | 6 | 0d38d126b1e653398426255e95449f1150eac1b0 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Plasma_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.00e-06 | 197 | 84 | 6 | 7ffb373d5b72c67e4816f14ea9a7a2024dc7a93a | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.00e-06 | 197 | 84 | 6 | 2e76e9ebd8702bfeefd396cbf5114eee0f24c19b | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.00e-06 | 197 | 84 | 6 | 207fce47e547fafbaf64a22efe3488e74bf19bed | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-06 | 197 | 84 | 6 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-06 | 197 | 84 | 6 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-06 | 197 | 84 | 6 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 2.06e-06 | 198 | 84 | 6 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.12e-06 | 199 | 84 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | NS-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.18e-06 | 200 | 84 | 6 | d51e5c8c154b073caaf0cc09a3a3c0aafd57e44b | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.18e-06 | 200 | 84 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.18e-06 | 200 | 84 | 6 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.18e-06 | 200 | 84 | 6 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.19e-06 | 137 | 84 | 5 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.41e-06 | 138 | 84 | 5 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-06 | 139 | 84 | 5 | c300f953ff9c5e820ff16bcd9942d279b37b79db | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-06 | 139 | 84 | 5 | 95b19d7459d9b54162cf01d278462245d34802d5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.72e-06 | 147 | 84 | 5 | 22d71cf92b957e5a8aa63b13157626d013d6752b | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 156 | 84 | 5 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 168 | 84 | 5 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-05 | 170 | 84 | 5 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 1.81e-05 | 171 | 84 | 5 | 976361f67dd725870e0513ae7a92f2dcaee17148 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-05 | 171 | 84 | 5 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 175 | 84 | 5 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B/Pre-B_transition|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.02e-05 | 175 | 84 | 5 | f86d2d212f8314b2410d5d84ef092b0b38607ea4 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 179 | 84 | 5 | b88791dd4e73bb8410ca090938a1a45b0bc16e69 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 179 | 84 | 5 | c063028b82c68d929aef2421daade9dc189a6963 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-05 | 181 | 84 | 5 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.64e-05 | 185 | 84 | 5 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.64e-05 | 185 | 84 | 5 | 709236097cbfc254796fcc69b5f5178b73dad9bd | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.64e-05 | 185 | 84 | 5 | af078a6c4a3e0b54b7d8ab7b30dcd06053ebfd28 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.64e-05 | 185 | 84 | 5 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.64e-05 | 185 | 84 | 5 | 698ff44fd2d9b3ad5cea45f4cff9bfc64c559b62 | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 2.71e-05 | 186 | 84 | 5 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.71e-05 | 186 | 84 | 5 | 981116561986f94e9cc3ee64fb37dab9a31d427a | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|World / disease group, cell group and cell class (v2) | 3.00e-05 | 190 | 84 | 5 | 7aaf82f0c235363afb95cf1fa51c2a5b070b1af8 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.08e-05 | 191 | 84 | 5 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 191 | 84 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.08e-05 | 191 | 84 | 5 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.08e-05 | 191 | 84 | 5 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 191 | 84 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 191 | 84 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.08e-05 | 191 | 84 | 5 | b23fdcd3090df9f58310b4dc8f7dc0c6d6b33226 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 192 | 84 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 193 | 84 | 5 | 9c2f58b4c89dc084a1a6e53952ea793e87a96660 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.23e-05 | 193 | 84 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 193 | 84 | 5 | db881cc129b45031fd84d052768cef53508de196 | |
| ToppCell | Biopsy_Control_(H.)-Immune-pDCs|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.40e-05 | 195 | 84 | 5 | 47d139215f0b51f5ea9b5fb09b1100e320e3f1e2 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 3.40e-05 | 195 | 84 | 5 | 1390728b9a514db534e8bc6dcf72cf51a1065780 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 195 | 84 | 5 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 195 | 84 | 5 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 195 | 84 | 5 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 197 | 84 | 5 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 3.57e-05 | 197 | 84 | 5 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.57e-05 | 197 | 84 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Caecum-B_cell-B_cell_cycling|Caecum / Region, Cell class and subclass | 3.65e-05 | 198 | 84 | 5 | 61294fe99a5641ad359796022c3d038470076b3c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-05 | 198 | 84 | 5 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.65e-05 | 198 | 84 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Caecum-(1)_T_cell-(18)_cycling_gd_T|Caecum / shred on region, Cell_type, and subtype | 3.65e-05 | 198 | 84 | 5 | 64278d8831c81874937e76b561c53928dfc437c5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-05 | 198 | 84 | 5 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | Caecum-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 3.65e-05 | 198 | 84 | 5 | d2def132f3efe9305a5501a96ec82efb1f02c3f7 | |
| ToppCell | Caecum-T_cell-cycling_gd_T|Caecum / Region, Cell class and subclass | 3.65e-05 | 198 | 84 | 5 | 5b719b67f8384863077070e1eb7e04a320e6dab4 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.65e-05 | 198 | 84 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Caecum-(2)_B_cell-(24)_B_cell_cycling|Caecum / shred on region, Cell_type, and subtype | 3.65e-05 | 198 | 84 | 5 | 568d47770cd20c6569ca84ea1eafde367642d68b | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.74e-05 | 199 | 84 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.74e-05 | 199 | 84 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.74e-05 | 199 | 84 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 3.74e-05 | 199 | 84 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 3.83e-05 | 200 | 84 | 5 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| Computational | Genes in the cancer module 89. | 4.34e-07 | 14 | 51 | 4 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 7.84e-07 | 16 | 51 | 4 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 1.02e-06 | 17 | 51 | 4 | MODULE_90 | |
| Computational | Chromatin and nucleosomes. | 1.31e-06 | 18 | 51 | 4 | MODULE_552 | |
| Computational | Genes in the cancer module 534. | 1.31e-06 | 18 | 51 | 4 | MODULE_534 | |
| Computational | Genes in the cancer module 222. | 3.09e-06 | 22 | 51 | 4 | MODULE_222 | |
| Computational | Genes in the cancer module 168. | 3.09e-06 | 22 | 51 | 4 | MODULE_168 | |
| Computational | Genes in the cancer module 189. | 3.72e-06 | 23 | 51 | 4 | MODULE_189 | |
| Computational | Genes in the cancer module 127. | 6.22e-06 | 26 | 51 | 4 | MODULE_127 | |
| Computational | Chromatin. | 8.46e-06 | 28 | 51 | 4 | MODULE_421 | |
| Computational | Muscle genes. | 2.64e-05 | 37 | 51 | 4 | MODULE_512 | |
| Computational | Genes in the cancer module 387. | 8.14e-05 | 49 | 51 | 4 | MODULE_387 | |
| Computational | Genes in the cancer module 201. | 8.81e-05 | 50 | 51 | 4 | MODULE_201 | |
| Computational | Genes in the cancer module 329. | 9.53e-05 | 51 | 51 | 4 | MODULE_329 | |
| Computational | Genes in the cancer module 202. | 3.03e-04 | 28 | 51 | 3 | MODULE_202 | |
| Computational | Testis genes. | 6.04e-04 | 310 | 51 | 7 | MODULE_72 | |
| Computational | Genes in the cancer module 429. | 1.94e-03 | 14 | 51 | 2 | MODULE_429 | |
| Drug | Methylmethacrylate | 1.37e-12 | 39 | 84 | 8 | ctd:D020366 | |
| Drug | Berberine | H2BC11 SETD2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC12 | 3.77e-09 | 202 | 84 | 10 | ctd:D001599 |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 4.33e-06 | 178 | 84 | 7 | 6220_UP | |
| Drug | Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 8.42e-06 | 197 | 84 | 7 | 7354_UP | |
| Drug | 2,3-bis(3'-hydroxybenzyl)butyrolactone | PKMYT1 SNRNP25 H2BC9 OXCT1 H2BC4 H2BC21 PYROXD1 SUPT16H H2BC5 RB1CC1 KMT2E BHLHE40 EPHA4 HELLS | 1.05e-05 | 961 | 84 | 14 | ctd:C029497 |
| Drug | OTX015 | 2.62e-05 | 16 | 84 | 3 | ctd:C000605331 | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.83e-05 | 160 | 84 | 6 | 5364_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 3.49e-05 | 166 | 84 | 6 | 3290_UP | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 3.73e-05 | 168 | 84 | 6 | 2801_UP | |
| Drug | rottlerin; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.98e-05 | 170 | 84 | 6 | 941_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 4.12e-05 | 171 | 84 | 6 | 5247_UP | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 4.12e-05 | 171 | 84 | 6 | 2723_UP | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 4.39e-05 | 173 | 84 | 6 | 3464_UP | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 4.68e-05 | 175 | 84 | 6 | 3295_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.83e-05 | 176 | 84 | 6 | 4632_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.99e-05 | 177 | 84 | 6 | 985_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.48e-05 | 180 | 84 | 6 | 6886_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 6.19e-05 | 184 | 84 | 6 | 2696_UP | |
| Drug | ferric oxide | 6.57e-05 | 186 | 84 | 6 | ctd:C000499 | |
| Disease | Inguinal hernia | 1.56e-05 | 287 | 82 | 7 | HP_0000023 | |
| Disease | Multiple pterygium syndrome | 4.56e-05 | 4 | 82 | 2 | C0265261 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 1.14e-04 | 6 | 82 | 2 | C1854678 | |
| Disease | sphingomyelin measurement | 1.27e-04 | 278 | 82 | 6 | EFO_0010118 | |
| Disease | Neurodevelopmental Disorders | 1.34e-04 | 93 | 82 | 4 | C1535926 | |
| Disease | urate measurement | SART1 H2BC4 SHANK2 DOK7 DHX38 RBM6 PIP5K1B ZNF318 JMJD1C EPHA4 | 1.86e-04 | 895 | 82 | 10 | EFO_0004531 |
| Disease | Congenital myopathy (disorder) | 4.94e-04 | 12 | 82 | 2 | C0270960 | |
| Disease | free cholesterol in IDL measurement | 6.63e-04 | 61 | 82 | 3 | EFO_0022181 | |
| Disease | Mammary Neoplasms | 6.67e-04 | 527 | 82 | 7 | C1458155 | |
| Disease | cholesteryl ester measurement | 7.62e-04 | 257 | 82 | 5 | EFO_0010351 | |
| Disease | Malignant neoplasm of breast | SETD2 H2BC4 TLE3 CHD5 DNAJC21 ROBO1 UMPS ZNF318 RB1CC1 H2BC12 | 7.79e-04 | 1074 | 82 | 10 | C0006142 |
| Disease | smoking status measurement, diastolic blood pressure | 1.02e-03 | 159 | 82 | 4 | EFO_0006336, EFO_0006527 | |
| Disease | serum hepcidin measurement | 1.13e-03 | 18 | 82 | 2 | EFO_0004504 | |
| Disease | age at menarche | 1.34e-03 | 594 | 82 | 7 | EFO_0004703 | |
| Disease | response to angiotensin-converting enzyme inhibitor | 1.35e-03 | 78 | 82 | 3 | EFO_0005325 | |
| Disease | age of onset of asthma | 1.40e-03 | 79 | 82 | 3 | OBA_2001001 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 1.55e-03 | 21 | 82 | 2 | OBA_2045156 | |
| Disease | Intellectual Disability | 1.55e-03 | 447 | 82 | 6 | C3714756 | |
| Disease | beta-aminoisobutyric acid measurement | 2.02e-03 | 24 | 82 | 2 | EFO_0010464 | |
| Disease | 3-hydroxybutyrate measurement | 2.20e-03 | 25 | 82 | 2 | EFO_0010982 | |
| Disease | lysophosphatidylethanolamine 18:2 measurement | 2.37e-03 | 26 | 82 | 2 | EFO_0010369 | |
| Disease | apolipoprotein A 1 measurement | 2.47e-03 | 848 | 82 | 8 | EFO_0004614 | |
| Disease | diet measurement | 2.52e-03 | 1049 | 82 | 9 | EFO_0008111 | |
| Disease | level of Phosphatidylethanolamine (18:0_18:2) in blood serum | 2.75e-03 | 28 | 82 | 2 | OBA_2045139 | |
| Disease | Adenoid Cystic Carcinoma | 2.76e-03 | 100 | 82 | 3 | C0010606 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRKAEKDSERDELYA | 481 | Q9BRD0 | |
| RKKDRDYLDKNSEKR | 906 | Q6UB99 | |
| KESTEKYKDRKDRAS | 1211 | Q6UB99 | |
| GYTRKLSAEELERKR | 331 | Q9NXE8 | |
| FIKGKERKTYQRRRE | 16 | P49711 | |
| RRKKKRIDDGDGYET | 326 | Q8TDI0 | |
| VYKSRRGIKRSEDSK | 36 | O14503 | |
| RGIKRSEDSKETYKL | 41 | O14503 | |
| ARYGKRSKSKERRAE | 176 | O14490 | |
| YEDVDLKSRRAGRKS | 501 | P78524 | |
| KERIAKRGRKLVDYD | 136 | Q9UBW5 | |
| DGRKRKRSRKESYSV | 26 | P57053 | |
| IRERKKTREYEKEAE | 466 | P49756 | |
| RDERKKDDRSRKRDY | 141 | Q5T8P6 | |
| DGKKRKRSRKESYSI | 26 | Q16778 | |
| DGKKRKRSRKESYSV | 26 | Q5QNW6 | |
| DGKKRKRSRKESYSI | 26 | P06899 | |
| DGKKRKRSRKESYSV | 26 | Q99877 | |
| VKDGKRLYEAEKSKR | 521 | Q8TDY2 | |
| SSESKKYERPKDDRE | 741 | P0C881 | |
| SSESKKYERPKDDRE | 741 | B2RC85 | |
| KSRDYEREIKGSREK | 776 | Q9NRZ9 | |
| DGKKRKRSRKESYSV | 26 | Q99879 | |
| DGKKRKRSRKESYSI | 26 | Q6DN03 | |
| DGKKRKRSRKESYSI | 26 | Q6DRA6 | |
| DKVNRRKAKRTYESG | 1611 | Q15652 | |
| RRRSKYSKAKQEADE | 571 | P54764 | |
| DGKKRKRSRKESYSV | 26 | P58876 | |
| DGKKRKRSRKESYSV | 26 | Q93079 | |
| DGKKRKRSRKESYSV | 26 | O60814 | |
| YTEIREREREKSEKG | 216 | Q9C000 | |
| GSTYKRRASRKEREK | 206 | O14986 | |
| EYRKRQREARKSGSK | 1161 | Q8IZD2 | |
| FEKRRSEGEKIRKKY | 11 | O95166 | |
| REKKRSYKDFLREEE | 31 | Q9UGU5 | |
| RRDASEEELKKAYRK | 11 | Q5F1R6 | |
| KGSTYKRRASQKERE | 261 | Q99755 | |
| DGKKRKRSRKESYSI | 26 | P33778 | |
| DGKKRKRSRKESYSV | 26 | P62807 | |
| SDGRTQKYCKEEDRK | 296 | A2AJT9 | |
| DGKKRKRSRKESYSV | 26 | Q99880 | |
| DGKKRKRSRKESYSI | 26 | P23527 | |
| TKYRSGRIRVKDKEG | 1316 | Q9HC77 | |
| ATRKISRKDGRYLDD | 71 | Q5VT06 | |
| YKDKSERIKGLRERS | 41 | Q18PE1 | |
| RREAKVKFEERYKTG | 111 | P61353 | |
| ERKYKGDSTIRELKA | 266 | Q6UVJ0 | |
| QERTKKKRRGDRYSV | 3491 | P21817 | |
| AAESRIKRLRDKYEA | 921 | Q9UPN4 | |
| RYEGKIARSSERFKE | 66 | Q14623 | |
| KEKGKKSSRDYRRAA | 146 | Q6ZNG9 | |
| DRDRKDKKRSYESAN | 361 | Q9Y383 | |
| RRTRIGYSFKKDEIE | 71 | Q9NYH9 | |
| PERKRIKYSRETDSD | 1026 | P78332 | |
| EDDLYKERTRKRRKS | 16 | Q68CJ6 | |
| EEGYRKLIDQKKDRR | 511 | P51531 | |
| SSESYKERVAKRERK | 241 | Q96RI9 | |
| KERASLDKKRDKDYR | 586 | Q9NWH9 | |
| ESVKGLRKYERRVKE | 1836 | P11055 | |
| KKKSRYERTDTGEIT | 81 | Q9P2R6 | |
| KGEKYEKRIERLSIR | 271 | P55809 | |
| RYKTREAEEKEKEGI | 631 | Q9Y5B9 | |
| KYETDLGRDRKGDDK | 1281 | Q9UPX8 | |
| RKIKDSDAYRRDELR | 481 | Q8TCY9 | |
| RERKRKRESKYSGID | 66 | Q6B0B8 | |
| KVRSKEDGRLYAVKR | 126 | Q99640 | |
| TRYTTEGRKKEARSK | 211 | Q8WU10 | |
| RIESYEGREKKGISD | 36 | O95772 | |
| AGEKLTEDRKKLRDY | 101 | Q9BV90 | |
| RRKETKDYGTKRLVE | 96 | P11172 | |
| EEKRDESTGVIYRKR | 41 | Q8N945 | |
| KEKSRDRDYDRKRDR | 156 | Q92620 | |
| EDEDPAARRRKKKSY | 66 | Q13123 | |
| AEKYRDRAKERRDGV | 96 | Q13123 | |
| RKDDGELPKSRYEIR | 296 | Q9Y6N7 | |
| RRVKREKRDDGYEAA | 91 | O43290 | |
| SEDRKAVRYERKKRN | 311 | Q495X7 | |
| EKIERDKAERAKKYG | 166 | Q04323 | |
| RRGKYSSKLERESKR | 506 | Q9BYW2 | |
| KRKAEEKDSLSRYDS | 226 | Q04726 | |
| VRKERSKESDDNYDK | 461 | Q9HD40 | |
| KGRVVREKEEERAKY | 116 | Q2TBF2 | |
| KLKGYSIRSEERSRE | 256 | Q5VUA4 | |
| YRDDNRDKDSEKTKR | 271 | Q6ZSZ6 | |
| EEDRKPERKESSRRY | 891 | Q5T200 | |
| DKGSRKRYEPSDKDR | 826 | Q86VM9 | |
| YEVILKDDRGKDKSR | 1426 | P52179 | |
| EKEYRKDLEESIRGK | 5971 | P20929 |